Publications published since 2000 from OUS - Department of Cancer Immunology

521 publications found

Publications 2020

  1. Bai B, Myklebust JH, Wälchli S (2020)
    Gene Editing in B-Lymphoma Cell Lines Using CRISPR/Cas9 Technology
    Methods Mol Biol, 2115, 445-454
    DOI 10.1007/978-1-0716-0290-4_25, PubMed 32006416
  2. Casey NP, Kyte JA, Fujiwara H (2020)
    Use of RNA Interference with TCR Transfer to Enhance Safety and Efficiency
    Methods Mol Biol, 2115, 327-349
    DOI 10.1007/978-1-0716-0290-4_18, PubMed 32006409
  3. Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
    Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
    Cancers (Basel), 12 (2)
    DOI 10.3390/cancers12020377, PubMed 32041351
  4. Iversen PO, Sioud M (2020)
    Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
    Methods Mol Biol, 2115, 281-287
    DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407
  5. Jakobsen LH, Ellin F, Smeland KB, Wästerlid T, Christensen JH, Jørgensen JM, Josefsson PL, Øvlisen AK, Holte H, Blaker YN, Grauslund JH, Bjørn J, Molin D, Lagerlöf I, Smedby KE, Colvin K, Thanarajasingam G, Maurer MJ, Habermann TM, Song KW, Zhu KY, Gerrie AS, Cheah CY, El-Galaly TC (2020)
    Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients
    Br J Haematol
    DOI 10.1111/bjh.16425, PubMed 32017050
  6. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
    Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 69 (1), 159-161
    DOI 10.1007/s00262-019-02409-6, PubMed 31776597
  7. Meås HZ, Haug M, Beckwith MS, Louet C, Ryan L, Hu Z, Landskron J, Nordbø SA, Taskén K, Yin H, Damås JK, Flo TH (2020)
    Sensing of HIV-1 by TLR8 activates human T cells and reverses latency
    Nat Commun, 11 (1), 147
    DOI 10.1038/s41467-019-13837-4, PubMed 31919342
  8. Mobergslien A, Sioud M (2020)
    Exploring 5'-Biotinylation of the Sense Strand to Improve siRNA Specificity and Potency
    Methods Mol Biol, 2115, 163-170
    DOI 10.1007/978-1-0716-0290-4_9, PubMed 32006400
  9. Rein ID, Notø HØ, Bostad M, Huse K, Stokke T (2020)
    Cell Cycle Analysis and Relevance for Single-Cell Gating in Mass Cytometry
    Cytometry A
    DOI 10.1002/cyto.a.23960, PubMed 31943748
  10. Sioud M (2020)
    RNA and CRISPR Interferences: Past, Present, and Future Perspectives
    Methods Mol Biol, 2115, 1-22
    DOI 10.1007/978-1-0716-0290-4_1, PubMed 32006392
  11. Sioud M (2020)
    Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
    Methods Mol Biol, 2115, 259-280
    DOI 10.1007/978-1-0716-0290-4_15, PubMed 32006406
  12. Sioud M (2020)
    Optimized siRNA Delivery into Primary Immune Cells Using Electroporation
    Methods Mol Biol, 2115, 119-131
    DOI 10.1007/978-1-0716-0290-4_7, PubMed 32006398
  13. Sæbøe-Larssen S, Sioud M (2020)
    Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
    Methods Mol Biol, 2115, 249-258
    DOI 10.1007/978-1-0716-0290-4_14, PubMed 32006405
  14. Wälchli S, Sioud M (2020)
    Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
    Methods Mol Biol, 2115, 407-417
    DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413

Publications 2019

  1. Ali M, Foldvari Z, Giannakopoulou E, Böschen ML, Strønen E, Yang W, Toebes M, Schubert B, Kohlbacher O, Schumacher TN, Olweus J (2019)
    Induction of neoantigen-reactive T cells from healthy donors
    Nat Protoc, 14 (6), 1926-1943
    DOI 10.1038/s41596-019-0170-6, PubMed 31101906
  2. Bartolomé-Casado R, Landsverk OJB, Chauhan SK, Richter L, Phung D, Greiff V, Risnes LF, Yao Y, Neumann RS, Yaqub S, Øyen O, Horneland R, Aandahl EM, Paulsen V, Sollid LM, Qiao SW, Baekkevold ES, Jahnsen FL (2019)
    Resident memory CD8 T cells persist for years in human small intestine
    J Exp Med, 216 (10), 2412-2426
    DOI 10.1084/jem.20190414, PubMed 31337737
  3. Brennecke P, Rasina D, Aubi O, Herzog K, Landskron J, Cautain B, Vicente F, Quintana J, Mestres J, Stechmann B, Ellinger B, Brea J, Kolanowski JL, Pilarski R, Orzaez M, Pineda-Lucena A, Laraia L, Nami F, Zielenkiewicz P, Paruch K, Hansen E, von Kries JP, Neuenschwander M, Specker E, Bartunek P et al. (2019)
    EU-OPENSCREEN: A Novel Collaborative Approach to Facilitate Chemical Biology
    SLAS Discov, 24 (3), 398-413
    DOI 10.1177/2472555218816276, PubMed 30616481
  4. Chellappa S, Kushekhar K, Munthe LA, Tjønnfjord GE, Aandahl EM, Okkenhaug K, Taskén K (2019)
    The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    J Immunol, 202 (5), 1397-1405
    DOI 10.4049/jimmunol.1701703, PubMed 30692213
  5. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK (2019)
    Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer
    Gastroenterology, 157 (4), 1067-1080.e9
    DOI 10.1053/j.gastro.2019.06.023, PubMed 31229495
  6. Cremaschi A, Argiento R, Shoemaker K, Peterson C, Vannucci M (2019)
    Hierarchical Normalized Completely Random Measures for Robust Graphical Modeling
    Bayesian Anal., 14 (4), 1271-1301
  7. Dukic AR, Gerbaud P, Guibourdenche J, Thiede B, Taskén K, Pidoux G (2019)
    Correction: Ezrin-anchored PKA phosphorylates serine 369 and 373 on connexin 43 to enhance gap junction assembly, communication, and cell fusion
    Biochem J, 476 (13), 1927
    DOI 10.1042/BCJ-2017-0529_COR, PubMed 31266855
  8. Enqvist M, Jacobs B, Junlén HR, Schaffer M, Melén CM, Friberg D, Wahlin BE, Malmberg KJ (2019)
    Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
    Front Immunol, 10, 2085
    DOI 10.3389/fimmu.2019.02085, PubMed 31572357
  9. Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, Schuetz C, Al-Herz W, Abraham RS, Joshi AY, Costa-Carvalho BT, Buchbinder D, Booth C, Reiff A, Ferguson PJ, Aghamohammadi A, Abolhassani H, Puck JM, Adeli M, Cancrini C, Palma P, Bertaina A, Locatelli F, Di Matteo G, Geha RS et al. (2019)
    Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency
    J Allergy Clin Immunol Pract, 7 (6), 1970-1985.e4
    DOI 10.1016/j.jaip.2019.02.038, PubMed 30877075
  10. GBD 2016 Stroke Collaborators (2019)
    Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
    Lancet Neurol, 18 (5), 439-458
    DOI 10.1016/S1474-4422(19)30034-1, PubMed 30871944
  11. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, Abebe ND, Abraha HN, Abu-Raddad LJ, Abualhasan A, Adedeji IA, Advani SM, Afarideh M, Afshari M, Aghaali M, Agius D, Agrawal S, Ahmadi A, Ahmadian E, Ahmadpour E et al. (2019)
    Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study
    JAMA Oncol (in press)
    DOI 10.1001/jamaoncol.2019.2996, PubMed 31560378
  12. Goodridge JP, Jacobs B, Saetersmoen ML, Clement D, Hammer Q, Clancy T, Skarpen E, Brech A, Landskron J, Grimm C, Pfefferle A, Meza-Zepeda L, Lorenz S, Wiiger MT, Louch WE, Ask EH, Liu LL, Oei VYS, Kjällquist U, Linnarsson S, Patel S, Taskén K, Stenmark H, Malmberg KJ (2019)
    Remodeling of secretory lysosomes during education tunes functional potential in NK cells
    Nat Commun, 10 (1), 514
    DOI 10.1038/s41467-019-08384-x, PubMed 30705279
  13. Huse K (2019)
    Expanding the Clinical Cytometry Toolbox-Receptor Occupancy by Mass Cytometry
    Cytometry A, 95 (10), 1046-1048
    DOI 10.1002/cyto.a.23784, PubMed 31046178
  14. Huse K, Wogsland CE, Polikowsky HG, Diggins KE, Smeland EB, Myklebust JH, Irish JM (2019)
    Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response
    Cytometry A, 95 (4), 442-449
    DOI 10.1002/cyto.a.23737, PubMed 30838773
  15. Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH (2019)
    TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
    Cancer Immunol Res, 7 (3), 355-362
    DOI 10.1158/2326-6066.CIR-18-0351, PubMed 30659053
  16. Kyte JA, Fåne A, Pule M, Gaudernack G (2019)
    Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
    Oncoimmunology, 8 (4), e1565236
    DOI 10.1080/2162402X.2019.1565236, PubMed 30906659
  17. Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2019)
    Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
    Blood Adv, 3 (8), 1230-1243
    DOI 10.1182/bloodadvances.2018029678, PubMed 30979721
  18. Mensali N, Dillard P, Hebeisen M, Lorenz S, Theodossiou T, Myhre MR, Fåne A, Gaudernack G, Kvalheim G, Myklebust JH, Inderberg EM, Wälchli S (2019)
    NK cells specifically TCR-dressed to kill cancer cells
    EBioMedicine, 40, 106-117
    DOI 10.1016/j.ebiom.2019.01.031, PubMed 30665853
  19. Mensali N, Grenov A, Pati NB, Dillard P, Myhre MR, Gaudernack G, Kvalheim G, Inderberg EM, Bakke O, Wälchli S (2019)
    Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity
    Oncoimmunology, 8 (3), 1558663
    DOI 10.1080/2162402X.2018.1558663, PubMed 30723591
  20. Mensali N, Myhre MR, Dillard P, Pollmann S, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2019)
    Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
    Cancer Immunol Immunother, 68 (8), 1235-1243
    DOI 10.1007/s00262-019-02356-2, PubMed 31214732
  21. Olweus J, Lund-Johansen F (2019)
    Finding Neo (antigens, that is)
    Blood, 134 (2), 108-109
    DOI 10.1182/blood.2019001334, PubMed 31296544
  22. Pfefferle A, Jacobs B, Netskar H, Ask EH, Lorenz S, Clancy T, Goodridge JP, Sohlberg E, Malmberg KJ (2019)
    Intra-lineage Plasticity and Functional Reprogramming Maintain Natural Killer Cell Repertoire Diversity
    Cell Rep, 29 (8), 2284-2294.e4
    DOI 10.1016/j.celrep.2019.10.058, PubMed 31747601
  23. Pällmann N, Livgård M, Tesikova M, Zeynep Nenseth H, Akkus E, Sikkeland J, Jin Y, Koc D, Kuzu OF, Pradhan M, Danielsen HE, Kahraman N, Mokhlis HM, Ozpolat B, Banerjee PP, Uren A, Fazli L, Rennie PS, Jin Y, Saatcioglu F (2019)
    Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
    Oncogene, 38 (35), 6301-6318
    DOI 10.1038/s41388-019-0879-2, PubMed 31312022
  24. Sioud M (2019)
    Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
    Cancers (Basel), 11 (2)
    DOI 10.3390/cancers11020176, PubMed 30717461
  25. Sioud M (2019)
    Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics
    Mol Biotechnol, 61 (4), 286-303
    DOI 10.1007/s12033-019-00156-8, PubMed 30729435
  26. Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
    Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
    Cancers (Basel), 11 (8)
    DOI 10.3390/cancers11081088, PubMed 31370273
  27. Skånland SS, Cieślar-Pobuda A (2019)
    Off-label uses of drugs for depression
    Eur J Pharmacol, 865, 172732
    DOI 10.1016/j.ejphar.2019.172732, PubMed 31622593
  28. Skånland SS, Cremaschi A, Bendiksen H, Hermansen JU, Thimiri Govinda Raj DB, Munthe LA, Tjønnfjord GE, Taskén K (2019)
    An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL
    Leukemia, 34 (2), 478-487
    DOI 10.1038/s41375-019-0569-7, PubMed 31471562
  29. Skånland SS, Taskén K (2019)
    Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling
    J Immunol, 203 (4), 1055-1063
    DOI 10.4049/jimmunol.1801660, PubMed 31292214
  30. Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
    A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
    Haematologica, 104 (10), e460-e464
    DOI 10.3324/haematol.2018.209080, PubMed 30846496
  31. Stiksrud B, Aass HCD, Lorvik KB, Ueland T, Trøseid M, Dyrhol-Riise AM (2019)
    Activated dendritic cells and monocytes in HIV immunological nonresponders: HIV-induced interferon-inducible protein-10 correlates with low future CD4+ recovery
    AIDS, 33 (7), 1117-1129
    DOI 10.1097/QAD.0000000000002173, PubMed 30789356
  32. Sukonina V, Ma H, Zhang W, Bartesaghi S, Subhash S, Heglind M, Foyn H, Betz MJ, Nilsson D, Lidell ME, Naumann J, Haufs-Brusberg S, Palmgren H, Mondal T, Beg M, Jedrychowski MP, Taskén K, Pfeifer A, Peng XR, Kanduri C, Enerbäck S (2019)
    FOXK1 and FOXK2 regulate aerobic glycolysis
    Nature, 566 (7743), 279-283
    DOI 10.1038/s41586-019-0900-5, PubMed 30700909
  33. Tekpli X, Lien T, Røssevold AH, Nebdal D, Borgen E, Ohnstad HO, Kyte JA, Vallon-Christersson J, Fongaard M, Due EU, Svartdal LG, Sveli MAT, Garred Ø, OSBREAC, Frigessi A, Sahlberg KK, Sørlie T, Russnes HG, Naume B, Kristensen VN (2019)
    An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
    Nat Commun, 10 (1), 5499
    DOI 10.1038/s41467-019-13329-5, PubMed 31796750
  34. Theodossiou TA, Ali M, Grigalavicius M, Grallert B, Dillard P, Schink KO, Olsen CE, Wälchli S, Inderberg EM, Kubin A, Peng Q, Berg K (2019)
    Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy
    NPJ Breast Cancer, 5, 13
    DOI 10.1038/s41523-019-0108-8, PubMed 30993194

Publications 2018

  1. Björklund AT, Carlsten M, Sohlberg E, Liu LL, Clancy T, Karimi M, Cooley S, Miller JS, Klimkowska M, Schaffer M, Watz E, Wikström K, Blomberg P, Wahlin BE, Palma M, Hansson L, Ljungman P, Hellström-Lindberg E, Ljunggren HG, Malmberg KJ (2018)
    Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
    Clin Cancer Res, 24 (8), 1834-1844
    DOI 10.1158/1078-0432.CCR-17-3196, PubMed 29444931
  2. De Santis F, Del Vecchio M, Castagnoli L, De Braud F, Di Cosimo S, Franceschini D, Fucà G, Hiscott J, Malmberg KJ, McGranahan N, Pietrantonio F, Rivoltini L, Sangaletti S, Tagliabue E, Tripodo C, Vernieri C, Zitvogel L, Pupa SM, Di Nicola M (2018)
    Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting
    Cytokine Growth Factor Rev, 44, 1-10
    DOI 10.1016/j.cytogfr.2018.10.005, PubMed 30393044
  3. Eide HA, Knudtsen IS, Sandhu V, Løndalen AM, Halvorsen AR, Abravan A, Kure EH, Bogsrud TV, Brustugun OT, Kyte JA, Malinen E, Helland Å (2018)
    Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
    Adv Radiat Oncol, 3 (2), 130-138
    DOI 10.1016/j.adro.2017.12.007, PubMed 29904737
  4. Hermansen JU, Tjønnfjord GE, Munthe LA, Taskén K, Skånland SS (2018)
    Cryopreservation of primary B cells minimally influences their signaling responses
    Sci Rep, 8 (1), 17651
    DOI 10.1038/s41598-018-36121-9, PubMed 30518828
  5. Holte H, Beiske K, Boyle M, Trøen G, Blaker YN, Myklebust J, Kvaløy S, Rosenwald A, Lingjaerde OC, Rimsza LM, Smeland EB, Scott DW, Kolstad A (2018)
    The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy
    Br J Haematol, 183 (2), 225-234
    DOI 10.1111/bjh.15518, PubMed 30080252
  6. Jacobs B, Pfefferle A, Clement D, Berg-Larsen A, Saetersmoen ML, Lorenz S, Wiiger MT, Goodridge JP, Malmberg KJ (2018)
    Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal
    J Immunol, 202 (3), 736-746
    DOI 10.4049/jimmunol.1801146, PubMed 30578306
  7. Lawless D, Geier CB, Farmer JR, Lango Allen H, Thwaites D, Atschekzei F, Brown M, Buchbinder D, Burns SO, Butte MJ, Csomos K, Deevi SVV, Egner W, Ehl S, Eibl MM, Fadugba O, Foldvari Z, Green DM, Henrickson SE, Holland SM, John T, Klemann C, Kuijpers TW, Moreira F, Piller A et al. (2018)
    Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency
    J Allergy Clin Immunol, 141 (6), 2303-2306
    DOI 10.1016/j.jaci.2018.02.007, PubMed 29477728
  8. Mottok A, Wright G, Rosenwald A, Ott G, Ramsower C, Campo E, Braziel RM, Delabie J, Weisenburger DD, Song JY, Chan WC, Cook JR, Fu K, Greiner T, Smeland E, Holte H, Savage KJ, Glinsmann-Gibson BJ, Gascoyne RD, Staudt LM, Jaffe ES, Connors JM, Scott DW, Steidl C, Rimsza LM (2018)
    Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens
    Blood, 132 (22), 2401-2405
    DOI 10.1182/blood-2018-05-851154, PubMed 30257882
  9. Oei VYS, Siernicka M, Graczyk-Jarzynka A, Hoel HJ, Yang W, Palacios D, Almåsbak H, Bajor M, Clement D, Brandt L, Önfelt B, Goodridge J, Winiarska M, Zagozdzon R, Olweus J, Kyte JA, Malmberg KJ (2018)
    Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors
    Cancer Immunol Res, 6 (4), 467-480
    DOI 10.1158/2326-6066.CIR-17-0207, PubMed 29459477
  10. Peng W, de Bruijn HS, Farrell E, Sioud M, Mashayekhi V, Oliveira S, van Dam GM, Roodenburg JLN, Witjes MJH, Robinson DJ (2018)
    Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines
    Lasers Surg Med, 50 (5), 513-522
    DOI 10.1002/lsm.22930, PubMed 29777587
  11. Rogne M, Chu DT, Küntziger TM, Mylonakou MN, Collas P, Tasken K (2018)
    OPA1-anchored PKA phosphorylates perilipin 1 on S522 and S497 in adipocytes differentiated from human adipose stem cells
    Mol Biol Cell, 29 (12), 1487-1501
    DOI 10.1091/mbc.E17-09-0538, PubMed 29688805
  12. Saetersmoen ML, Hammer Q, Valamehr B, Kaufman DS, Malmberg KJ (2018)
    Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
    Semin Immunopathol, 41 (1), 59-68
    DOI 10.1007/s00281-018-0721-x, PubMed 30361801
  13. Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M et al. (2018)
    Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects
    J Allergy Clin Immunol, 142 (6), 1932-1946
    DOI 10.1016/j.jaci.2018.02.055, PubMed 29729943
  14. Sioud M (2018)
    T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors
    Scand J Immunol, 87 (3)
    DOI 10.1111/sji.12643, PubMed 29381830
  15. Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
    Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
    FASEB J, 32 (9), 5063-5077
    DOI 10.1096/fj.201701544R, PubMed 29913558
  16. Tutturen AEV, Dørum S, Clancy T, Reims HM, Christophersen A, Lundin KEA, Sollid LM, de Souza GA, Stamnaes J (2018)
    Characterization of the Small Intestinal Lesion in Celiac Disease by Label-Free Quantitative Mass Spectrometry
    Am J Pathol, 188 (7), 1563-1579
    DOI 10.1016/j.ajpath.2018.03.017, PubMed 29684362
  17. Vodák D, Lorenz S, Nakken S, Aasheim LB, Holte H, Bai B, Myklebost O, Meza-Zepeda LA, Hovig E (2018)
    Sample-Index Misassignment Impacts Tumour Exome Sequencing
    Sci Rep, 8 (1), 5307
    DOI 10.1038/s41598-018-23563-4, PubMed 29593270
  18. Våtsveen TK, Myhre MR, Steen CB, Wälchli S, Lingjærde OC, Bai B, Dillard P, Theodossiou TA, Holien T, Sundan A, Inderberg EM, Smeland EB, Myklebust JH, Oksvold MP (2018)
    Artesunate shows potent anti-tumor activity in B-cell lymphoma
    J Hematol Oncol, 11 (1), 23
    DOI 10.1186/s13045-018-0561-0, PubMed 29458389

Publications 2017

  1. Bollum LK, Huse K, Oksvold MP, Bai B, Hilden VI, Forfang L, Yoon SO, Wälchli S, Smeland EB, Myklebust JH (2017)
    BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5
    PLoS One, 12 (5), e0177188
    DOI 10.1371/journal.pone.0177188, PubMed 28489883
  2. Clancy T, Dannenfelser R, Troyanskaya O, Malmberg KJ, Hovig E, Kristensen V (2017)
    Bioinformatics Approaches to Profile the Tumor Microenvironment for Immunotherapeutic Discovery
    Curr Pharm Des, 23 (32), 4716-4725
    DOI 10.2174/1381612823666170710154936, PubMed 28699527
  3. Inderberg EM, Mensali N, Oksvold MP, Fallang LE, Fåne A, Skorstad G, Stenvik GE, Progida C, Bakke O, Kvalheim G, Myklebust JH, Wälchli S (2017)
    Human c-SRC kinase (CSK) overexpression makes T cells dummy
    Cancer Immunol Immunother, 67 (4), 525-536
    DOI 10.1007/s00262-017-2105-9, PubMed 29248956
  4. Inderberg EM, Wälchli S, Myhre MR, Trachsel S, Almåsbak H, Kvalheim G, Gaudernack G (2017)
    T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
    Oncoimmunology, 6 (4), e1302631
    DOI 10.1080/2162402X.2017.1302631, PubMed 28507809
  5. Jha SK, Rauniyar K, Karpanen T, Leppänen VM, Brouillard P, Vikkula M, Alitalo K, Jeltsch M (2017)
    Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
    Sci Rep, 7 (1), 4916
    DOI 10.1038/s41598-017-04982-1, PubMed 28687807
  6. Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2017)
    T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling
    Clin Cancer Res, 24 (4), 870-881
    DOI 10.1158/1078-0432.CCR-17-2337, PubMed 29217528
  7. Kanaya M, Hayashi Y, Hashimoto D, Endo T, Sugita J, Ohigashi H, Hashiguchi J, Matsukawa T, Matsuoka S, Kosugi-Kanaya M, Goto H, Onozawa M, Kahata K, Fujimoto K, Kondo T, Akizawa K, Shibuya H, Shimizu C, Teshima T (2017)
    MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase
    Bone Marrow Transplant, 52 (5), 778-780
    DOI 10.1038/bmt.2016.365, PubMed 28134922
  8. Karpanen T, Olweus J (2017)
    The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
    Front Immunol, 8, 1718
    DOI 10.3389/fimmu.2017.01718, PubMed 29321773
  9. Karpanen T, Padberg Y, van de Pavert SA, Dierkes C, Morooka N, Peterson-Maduro J, van de Hoek G, Adrian M, Mochizuki N, Sekiguchi K, Kiefer F, Schulte D, Schulte-Merker S (2017)
    An Evolutionarily Conserved Role for Polydom/Svep1 During Lymphatic Vessel Formation
    Circ Res, 120 (8), 1263-1275
    DOI 10.1161/CIRCRESAHA.116.308813, PubMed 28179432
  10. Koksal H, Walchli S (2017)
    Fishing therapeutic T-cell receptors in healthy donor blood, is safety predictable?
    Transl. Cancer Res., 6 3, S622-S624
  11. Lilleby W, Gaudernack G, Brunsvig PF, Vlatkovic L, Schulz M, Mills K, Hole KH, Inderberg EM (2017)
    Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer
    Cancer Immunol Immunother, 66 (7), 891-901
    DOI 10.1007/s00262-017-1994-y, PubMed 28391357
  12. Liu LL, Béziat V, Oei VYS, Pfefferle A, Schaffer M, Lehmann S, Hellström-Lindberg E, Söderhäll S, Heyman M, Grandér D, Malmberg KJ (2017)
    Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells
    Cancer Immunol Res, 5 (8), 654-665
    DOI 10.1158/2326-6066.CIR-16-0296, PubMed 28637877
  13. Malmberg KJ, Carlsten M, Björklund A, Sohlberg E, Bryceson YT, Ljunggren HG (2017)
    Natural killer cell-mediated immunosurveillance of human cancer
    Semin Immunol, 31, 20-29
    DOI 10.1016/j.smim.2017.08.002, PubMed 28888619
  14. Malmberg KJ, Sohlberg E, Goodridge JP, Ljunggren HG (2017)
    Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell "missing self" recognition
    Immunogenetics, 69 (8-9), 547-556
    DOI 10.1007/s00251-017-1011-9, PubMed 28699110
  15. Olweus J (2017)
    Manufacture of CAR-T cells in the body
    Nat Biotechnol, 35 (6), 520-521
    DOI 10.1038/nbt.3898, PubMed 28591119
  16. Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø (2017)
    Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study
    Arthritis Res Ther, 19 (1), 284
    DOI 10.1186/s13075-017-1494-7, PubMed 29268795
  17. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
    Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
    Sci Rep, 7, 39710
    DOI 10.1038/srep39710, PubMed 28054583
  18. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
    Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
    J Autoimmun, 81, 110-119
    DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239
  19. Wagner JA, Rosario M, Romee R, Berrien-Elliott MM, Schneider SE, Leong JW, Sullivan RP, Jewell BA, Becker-Hapak M, Schappe T, Abdel-Latif S, Ireland AR, Jaishankar D, King JA, Vij R, Clement D, Goodridge J, Malmberg KJ, Wong HC, Fehniger TA (2017)
    CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
    J Clin Invest, 127 (11), 4042-4058
    DOI 10.1172/JCI90387, PubMed 28972539
  20. Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S (2017)
    A TCR-based Chimeric Antigen Receptor
    Sci Rep, 7 (1), 10713
    DOI 10.1038/s41598-017-11126-y, PubMed 28878363
  21. Wogsland CE, Greenplate AR, Kolstad A, Myklebust JH, Irish JM, Huse K (2017)
    Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations
    Cytometry B Clin Cytom, 92 (1), 79-87
    DOI 10.1002/cyto.b.21498, PubMed 27933753

Publications 2016

  1. Bai B, Laiho M (2016)
    Deep Sequencing Analysis of Nucleolar Small RNAs: Bioinformatics
    Methods Mol Biol, 1455, 243-8
    DOI 10.1007/978-1-4939-3792-9_19, PubMed 27576724
  2. Bai B, Laiho M (2016)
    Deep Sequencing Analysis of Nucleolar Small RNAs: RNA Isolation and Library Preparation
    Methods Mol Biol, 1455, 231-41
    DOI 10.1007/978-1-4939-3792-9_18, PubMed 27576723
  3. Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Wälchli S, König S, Salazar AM, Hartley O, Dietrich PY, Walker PR, Derouazi M (2016)
    Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants
    Mol Ther, 24 (9), 1675-85
    DOI 10.1038/mt.2016.134, PubMed 27377043
  4. Björklund AT, Clancy T, Goodridge JP, Béziat V, Schaffer M, Hovig E, Ljunggren HG, Ljungman PT, Malmberg KJ (2016)
    Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
    J Immunol, 196 (3), 1400-11
    DOI 10.4049/jimmunol.1501434, PubMed 26746188
  5. Blaker YN, Spetalen S, Brodtkorb M, Lingjaerde OC, Beiske K, Østenstad B, Sander B, Wahlin BE, Melen CM, Myklebust JH, Holte H, Delabie J, Smeland EB (2016)
    The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
    Br J Haematol, 175 (1), 102-14
    DOI 10.1111/bjh.14201, PubMed 27341313
  6. Cairns L, Aspeslagh S, Anichini A, Kyte JA, Blank C, Ascierto P, Rekers N, Straten PT, Awada A (2016)
    Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation
    Ecancermedicalscience, 10, 691
    DOI 10.3332/ecancer.2016.691, PubMed 27994647
  7. Clancy T, Hovig E (2016)
    Profiling networks of distinct immune-cells in tumors
    BMC Bioinformatics, 17 (1), 263
    DOI 10.1186/s12859-016-1141-3, PubMed 27377892
  8. Eide HA, Halvorsen AR, Sandhu V, Fåne A, Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA, Helland Å (2016)
    Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
    Clin Transl Immunology, 5 (11), e109
    DOI 10.1038/cti.2016.65, PubMed 27990285
  9. Henrich FC, Singer K, Poller K, Bernhardt L, Strobl CD, Limm K, Ritter AP, Gottfried E, Völkl S, Jacobs B, Peter K, Mougiakakos D, Dettmer K, Oefner PJ, Bosserhoff AK, Kreutz MP, Aigner M, Mackensen A (2016)
    Suppressive effects of tumor cell-derived 5'-deoxy-5'-methylthioadenosine on human T cells
    Oncoimmunology, 5 (8), e1184802
    DOI 10.1080/2162402X.2016.1184802, PubMed 27622058
  10. Henriksen EK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E (2016)
    Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
    J Hepatol, 66 (1), 116-122
    DOI 10.1016/j.jhep.2016.09.002, PubMed 27647428
  11. Holm KL, Indrevaer RL, Myklebust JH, Kolstad A, Moskaug JØ, Naderi EH, Blomhoff HK (2016)
    Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis
    Immunology, 149 (1), 62-73
    DOI 10.1111/imm.12629, PubMed 27278254
  12. Horowitz A, Djaoud Z, Nemat-Gorgani N, Blokhuis J, Hilton HG, Béziat V, Malmberg KJ, Norman PJ, Guethlein LA, Parham P (2016)
    Class I HLA haplotypes form two schools that educate NK cells in different ways
    Sci Immunol, 1 (3)
    DOI 10.1126/sciimmunol.aag1672, PubMed 27868107
  13. Kyte JA, Gaudernack G, Faane A, Lislerud K, Inderberg EM, Brunsvig P, Aamdal S, Kvalheim G, Wälchli S, Pule M (2016)
    T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy
    Oncoimmunology, 5 (12), e1249090
    DOI 10.1080/2162402X.2016.1249090, PubMed 28123886
  14. Kyte JA, Aamdal S, Dueland S, Sæbøe-Larsen S, Inderberg EM, Madsbu UE, Skovlund E, Gaudernack G, Kvalheim G (2016)
    Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cells
    Oncoimmunology, 5 (11), e1232237
    DOI 10.1080/2162402X.2016.1232237, PubMed 27999747
  15. Landtwing V, Raykova A, Pezzino G, Béziat V, Marcenaro E, Graf C, Moretta A, Capaul R, Zbinden A, Ferlazzo G, Malmberg KJ, Chijioke O, Münz C (2016)
    Cognate HLA absence in trans diminishes human NK cell education
    J Clin Invest, 126 (10), 3772-3782
    DOI 10.1172/JCI86923, PubMed 27571408
  16. Liu LL, Landskron J, Ask EH, Enqvist M, Sohlberg E, Traherne JA, Hammer Q, Goodridge JP, Larsson S, Jayaraman J, Oei VYS, Schaffer M, Taskén K, Ljunggren HG, Romagnani C, Trowsdale J, Malmberg KJ, Béziat V (2016)
    Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
    Cell Rep, 15 (5), 1088-1099
    DOI 10.1016/j.celrep.2016.04.005, PubMed 27117418
  17. Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
    Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
    Oncoimmunology, 5 (5), e1138199
    DOI 10.1080/2162402X.2016.1138199, PubMed 27467957
  18. Mobergslien A, Peng Q, Vasovic V, Sioud M (2016)
    Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth
    Oncotarget, 7 (46), 75940-75953
    DOI 10.18632/oncotarget.12445, PubMed 27713158
  19. Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, Wälchli S, Green MR, Trøen G, Liestøl K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R (2016)
    Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
    Blood, 129 (6), 759-770
    DOI 10.1182/blood-2016-05-718494, PubMed 28011673
  20. Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
    Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
    Case Rep Med, 2016, 9639585
    DOI 10.1155/2016/9639585, PubMed 27504122
  21. Strønen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, Donia M, Böschen ML, Lund-Johansen F, Olweus J, Schumacher TN (2016)
    Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
    Science, 352 (6291), 1337-41
    DOI 10.1126/science.aaf2288, PubMed 27198675
  22. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
    Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
    Clin Immunol, 175, 69-74
    DOI 10.1016/j.clim.2016.11.014, PubMed 27919819
  23. Tognarelli S, Jacobs B, Staiger N, Ullrich E (2016)
    Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
    J Vis Exp (116)
    DOI 10.3791/54615, PubMed 27842341
  24. Våtsveen TK, Børset M, Dikic A, Tian E, Micci F, Lid AH, Meza-Zepeda LA, Coward E, Waage A, Sundan A, Kuehl WM, Holien T (2016)
    VOLIN and KJON-Two novel hyperdiploid myeloma cell lines
    Genes Chromosomes Cancer, 55 (11), 890-901
    DOI 10.1002/gcc.22388, PubMed 27311012
  25. Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA (2016)
    Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies
    J Allergy Clin Immunol Pract, 4 (6), 1089-1100
    DOI 10.1016/j.jaip.2016.08.004, PubMed 27836058
  26. Winnay JN, Solheim MH, Dirice E, Sakaguchi M, Noh HL, Kang HJ, Takahashi H, Chudasama KK, Kim JK, Molven A, Kahn CR, Njølstad PR (2016)
    PI3-kinase mutation linked to insulin and growth factor resistance in vivo
    J Clin Invest, 126 (4), 1401-12
    DOI 10.1172/JCI84005, PubMed 26974159
  27. Zhao F, Sucker A, Horn S, Heeke C, Bielefeld N, Schrörs B, Bicker A, Lindemann M, Roesch A, Gaudernack G, Stiller M, Becker JC, Lennerz V, Wölfel T, Schadendorf D, Griewank K, Paschen A (2016)
    Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency
    Cancer Res, 76 (15), 4347-58
    DOI 10.1158/0008-5472.CAN-16-0008, PubMed 27261508
  28. Zins K, Schäfer R, Paulus P, Dobler S, Fakhari N, Sioud M, Aharinejad S, Abraham D (2016)
    Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
    Oncotarget, 7 (29), 46187-46202
    DOI 10.18632/oncotarget.10070, PubMed 27323822

Publications 2015

  1. Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
    Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
    Gene Ther, 22 (5), 391-403
    DOI 10.1038/gt.2015.4, PubMed 25652098
  2. Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ (2015)
    Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
    Front Immunol, 6, 507
    DOI 10.3389/fimmu.2015.00507, PubMed 26500647
  3. Blaker YN, Brodtkorb M, Maddison J, Hveem TS, Nesheim JA, Mohn HM, Kolstad A, Geisler CH, Liestøl K, Smeland EB, Holte H, Delabie J, Danielsen H (2015)
    Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma
    Histopathology, 67 (1), 62-9
    DOI 10.1111/his.12624, PubMed 25431344
  4. Blix ES, Kildal AB, Bertelsen E, Waage A, Myklebust JH, Kolstad A, Husebekk A (2015)
    Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma
    Biol Blood Marrow Transplant, 21 (5), 840-7
    DOI 10.1016/j.bbmt.2014.12.027, PubMed 25689789
  5. Dale Rein I, Stokke C, Jalal M, Myklebust JH, Patzke S, Stokke T (2015)
    New distinct compartments in the G2 phase of the cell cycle defined by the levels of γH2AX
    Cell Cycle, 14 (20), 3261-9
    DOI 10.1080/15384101.2015.1087617, PubMed 26317799
  6. Enqvist M, Ask EH, Forslund E, Carlsten M, Abrahamsen G, Béziat V, Andersson S, Schaffer M, Spurkland A, Bryceson Y, Önfelt B, Malmberg KJ (2015)
    Coordinated expression of DNAM-1 and LFA-1 in educated NK cells
    J Immunol, 194 (9), 4518-27
    DOI 10.4049/jimmunol.1401972, PubMed 25825444
  7. Forslund E, Sohlberg E, Enqvist M, Olofsson PE, Malmberg KJ, Önfelt B (2015)
    Microchip-Based Single-Cell Imaging Reveals That CD56dimCD57-KIR-NKG2A+ NK Cells Have More Dynamic Migration Associated with Increased Target Cell Conjugation and Probability of Killing Compared to CD56dimCD57-KIR-NKG2A- NK Cells
    J Immunol, 195 (7), 3374-81
    DOI 10.4049/jimmunol.1500171, PubMed 26320254
  8. Goodridge JP, Önfelt B, Malmberg KJ (2015)
    Newtonian cell interactions shape natural killer cell education
    Immunol Rev, 267 (1), 197-213
    DOI 10.1111/imr.12325, PubMed 26284479
  9. Hansen GL, Gaudernack G, Brunsvig PF, Cvancarova M, Kyte JA (2015)
    Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination
    Cancer Immunol Immunother, 64 (12), 1609-21
    DOI 10.1007/s00262-015-1766-5, PubMed 26498005
  10. Haabeth OA, Lorvik KB, Yagita H, Bogen B, Corthay A (2015)
    Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells
    Oncoimmunology, 5 (1), e1039763
    DOI 10.1080/2162402X.2015.1039763, PubMed 26942052
  11. Iversen PO, Sioud M (2015)
    Engineering therapeutic cancer vaccines that activate antitumor immunity
    Methods Mol Biol, 1218, 263-8
    DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656
  12. Jacobs B, Tognarelli S, Poller K, Bader P, Mackensen A, Ullrich E (2015)
    NK Cell Subgroups, Phenotype, and Functions After Autologous Stem Cell Transplantation
    Front Immunol, 6, 583
    DOI 10.3389/fimmu.2015.00583, PubMed 26635797
  13. Karpanen T, Olweus J (2015)
    T-cell receptor gene therapy--ready to go viral?
    Mol Oncol, 9 (10), 2019-42
    DOI 10.1016/j.molonc.2015.10.006, PubMed 26548533
  14. Kolstad A, Olweus J (2015)
    "In situ" vaccination for systemic effects in follicular lymphoma
    Oncoimmunology, 4 (7), e1014773
    DOI 10.1080/2162402X.2015.1014773, PubMed 26140239
  15. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
    Hepatology, 63 (5), 1608-19
    DOI 10.1002/hep.28116, PubMed 26257205
  16. Liu LL, Pfefferle A, Yi Sheng VO, Björklund AT, Béziat V, Goodridge JP, Malmberg KJ (2015)
    Harnessing adaptive natural killer cells in cancer immunotherapy
    Mol Oncol, 9 (10), 1904-17
    DOI 10.1016/j.molonc.2015.10.001, PubMed 26604011
  17. Mobergslien A, Sioud M (2015)
    A facile method for interfering with off-target silencing mediated by the sense strand
    Methods Mol Biol, 1218, 293-300
    DOI 10.1007/978-1-4939-1538-5_18, PubMed 25319659
  18. Mobergslien A, Vasovic V, Mathiesen G, Fredriksen L, Westby P, Eijsink VG, Peng Q, Sioud M (2015)
    Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells
    Hum Vaccin Immunother, 11 (11), 2664-73
    DOI 10.1080/21645515.2015.1056952, PubMed 26185907
  19. Oksvold MP (2015)
    Incidence of Data Duplications in a Randomly Selected Pool of Life Science Publications
    Sci Eng Ethics, 22 (2), 487-96
    DOI 10.1007/s11948-015-9668-7, PubMed 26065681
  20. Oksvold MP, Duyvestyn JM, Dagger SA, Taylor SJ, Forfang L, Myklebust JH, Smeland EB, Langdon WY (2015)
    The targeting of human and mouse B lymphocytes by dasatinib
    Exp Hematol, 43 (5), 352-363.e4
    DOI 10.1016/j.exphem.2015.01.008, PubMed 25641047
  21. Oksvold MP, Neurauter A, Pedersen KW (2015)
    Magnetic bead-based isolation of exosomes
    Methods Mol Biol, 1218, 465-81
    DOI 10.1007/978-1-4939-1538-5_27, PubMed 25319668
  22. Olweus J (2015)
    Cancer immunotherapy--Converting immune failure to clinical response
    Mol Oncol, 9 (10), 1891-3
    DOI 10.1016/j.molonc.2015.10.017, PubMed 26563645
  23. Polikowsky HG, Wogsland CE, Diggins KE, Huse K, Irish JM (2015)
    Cutting Edge: Redox Signaling Hypersensitivity Distinguishes Human Germinal Center B Cells
    J Immunol, 195 (4), 1364-1367
    DOI 10.4049/jimmunol.1500904, PubMed 26157177
  24. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT (2015)
    Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function
    Immunity, 42 (3), 443-56
    DOI 10.1016/j.immuni.2015.02.008, PubMed 25786176
  25. Sioud M (2015)
    Strategies for siRNA navigation to desired cells
    Methods Mol Biol, 1218, 201-16
    DOI 10.1007/978-1-4939-1538-5_12, PubMed 25319653
  26. Sioud M (2015)
    Overcoming the challenges of siRNA activation of innate immunity: design better therapeutic siRNAs
    Methods Mol Biol, 1218, 301-19
    DOI 10.1007/978-1-4939-1538-5_19, PubMed 25319660
  27. Sioud M (2015)
    RNA interference: mechanisms, technical challenges, and therapeutic opportunities
    Methods Mol Biol, 1218, 1-15
    DOI 10.1007/978-1-4939-1538-5_1, PubMed 25319642
  28. Sioud M (2015)
    Modified 2'-ribose small RNAs function as Toll-like receptor-7/8 antagonists
    Methods Mol Biol, 1218, 483-9
    DOI 10.1007/978-1-4939-1538-5_28, PubMed 25319669
  29. Sioud M (2015)
    Cytoplasmic delivery of siRNAs to monocytes and dendritic cells via electroporation
    Methods Mol Biol, 1218, 107-15
    DOI 10.1007/978-1-4939-1538-5_6, PubMed 25319647
  30. Sioud M, Mobergslien A, Sæbøe-Larssen S (2015)
    Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses
    Methods Mol Biol, 1218, 269-76
    DOI 10.1007/978-1-4939-1538-5_16, PubMed 25319657
  31. Sioud M, Westby P, Olsen JK, Mobergslien A (2015)
    Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
    Mol Ther Methods Clin Dev, 2, 15043
    DOI 10.1038/mtm.2015.43, PubMed 26605373
  32. Sobecks RM, Wang T, Askar M, Gallagher MM, Haagenson M, Spellman S, Fernandez-Vina M, Malmberg KJ, Müller C, Battiwalla M, Gajewski J, Verneris MR, Ringdén O, Marino S, Davies S, Dehn J, Bornhäuser M, Inamoto Y, Woolfrey A, Shaw P, Pollack M, Weisdorf D, Milller J, Hurley C, Lee SJ et al. (2015)
    Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation
    Biol Blood Marrow Transplant, 21 (9), 1589-96
    DOI 10.1016/j.bbmt.2015.05.002, PubMed 25960307
  33. Sohlberg E, Pfefferle A, Andersson S, Baumann BC, Hellström-Lindberg E, Malmberg KJ (2015)
    Imprint of 5-azacytidine on the natural killer cell repertoire during systemic treatment for high-risk myelodysplastic syndrome
    Oncotarget, 6 (33), 34178-90
    DOI 10.18632/oncotarget.6213, PubMed 26497557
  34. Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
    Unpredicted phenotypes of two mutants of the TcR DMF5
    J Immunol Methods, 425, 37-44
    DOI 10.1016/j.jim.2015.06.006, PubMed 26079729
  35. Theodossiou TA, Wälchli S, Olsen CE, Skarpen E, Berg K (2015)
    Deciphering the Nongenomic, Mitochondrial Toxicity of Tamoxifens As Determined by Cell Metabolism and Redox Activity
    ACS Chem Biol, 11 (1), 251-62
    DOI 10.1021/acschembio.5b00734, PubMed 26569462
  36. von Bahr L, Blennow O, Alm J, Björklund A, Malmberg KJ, Mougiakakos D, Le Blanc A, Oefner PJ, Labopin M, Ljungman P, Le Blanc K (2015)
    Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
    Bone Marrow Transplant, 50 (9), 1217-23
    DOI 10.1038/bmt.2015.123, PubMed 26030049
  37. Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J (2015)
    Soluble T-cell receptors produced in human cells for targeted delivery
    PLoS One, 10 (4), e0119559
    DOI 10.1371/journal.pone.0119559, PubMed 25875651
  38. Zins K, Sioud M, Aharinejad S, Lucas T, Abraham D (2015)
    Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy
    Methods Mol Biol, 1218, 143-61
    DOI 10.1007/978-1-4939-1538-5_9, PubMed 25319650

Publications 2014

  1. Anttonen T, Belevich I, Kirjavainen A, Laos M, Brakebusch C, Jokitalo E, Pirvola U (2014)
    How to bury the dead: elimination of apoptotic hair cells from the hearing organ of the mouse
    J Assoc Res Otolaryngol, 15 (6), 975-92
    DOI 10.1007/s10162-014-0480-x, PubMed 25074370
  2. Azzi T, Lünemann A, Murer A, Ueda S, Béziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Münz C, Chijioke O, Nadal D (2014)
    Role for early-differentiated natural killer cells in infectious mononucleosis
    Blood, 124 (16), 2533-43
    DOI 10.1182/blood-2014-01-553024, PubMed 25205117
  3. Bethge N, Honne H, Andresen K, Hilden V, Trøen G, Liestøl K, Holte H, Delabie J, Lind GE, Smeland EB (2014)
    A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma
    PLoS One, 9 (9), e104249
    DOI 10.1371/journal.pone.0104249, PubMed 25226156
  4. Béziat V, Traherne J, Malmberg JA, Ivarsson MA, Björkström NK, Retière C, Ljunggren HG, Michaëlsson J, Trowsdale J, Malmberg KJ (2014)
    Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation
    Eur J Immunol, 44 (7), 2192-6
    DOI 10.1002/eji.201444464, PubMed 24723455
  5. Blaker YN, Eide MB, Liestøl K, Lauritzsen GF, Kolstad A, Fosså A, Smeland EB, Holte H (2014)
    High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era
    Leuk Lymphoma, 55 (10), 2319-27
    DOI 10.3109/10428194.2013.871632, PubMed 24432894
  6. Calejo AI, Reverendo M, Silva VS, Pereira PM, Santos MA, Zorec R, Gonçalves PP (2014)
    Differences in the expression pattern of HCN isoforms among mammalian tissues: sources and implications
    Mol Biol Rep, 41 (1), 297-307
    DOI 10.1007/s11033-013-2862-2, PubMed 24234751
  7. Fiskvik I, Beiske K, Delabie J, Yri O, Spetalen S, Karjalainen-Lindsberg ML, Leppä S, Liestøl K, Smeland EB, Holte H (2014)
    Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma
    Leuk Lymphoma, 56 (6), 1742-9
    DOI 10.3109/10428194.2014.970550, PubMed 25284491
  8. Haugaa H, Taraldsrud E, Nyrerød HC, Tønnessen TI, Foss A, Solheim BG (2014)
    Low incidence of hyperfibrinolysis and thromboembolism in 195 primary liver transplantations transfused with solvent/detergent-treated plasma
    Clin Med Res, 12 (1-2), 27-32
    DOI 10.3121/cmr.2013.1168, PubMed 24415744
  9. Kolstad A, Kumari S, Walczak M, Madsbu U, Hagtvedt T, Bogsrud TV, Kvalheim G, Holte H, Aurlien E, Delabie J, Tierens A, Olweus J (2014)
    Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
    Blood, 125 (1), 82-9
    DOI 10.1182/blood-2014-07-592162, PubMed 25293773
  10. Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
    High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
    Eur J Immunol, 44 (11), 3439-52
    DOI 10.1002/eji.201444662, PubMed 25103993
  11. Lunemann S, Malone DF, Grabowski J, Port K, Béziat V, Bremer B, Malmberg KJ, Manns MP, Sandberg JK, Cornberg M, Ljunggren HG, Wedemeyer H, Björkström NK (2014)
    Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals
    Gut, 64 (3), 469-82
    DOI 10.1136/gutjnl-2014-306767, PubMed 24721903
  12. Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S, Thatcher N, Wagstaff J, Zielinski C, Faulkner I, Mellstedt H (2014)
    Therapeutic vaccines for cancer: an overview of clinical trials
    Nat Rev Clin Oncol, 11 (9), 509-24
    DOI 10.1038/nrclinonc.2014.111, PubMed 25001465
  13. Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers MH, Spits H, Malmberg KJ, Hazenberg MD (2014)
    Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease
    Blood, 124 (5), 812-21
    DOI 10.1182/blood-2013-11-536888, PubMed 24855210
  14. Oksvold MP, Kullmann A, Forfang L, Kierulf B, Li M, Brech A, Vlassov AV, Smeland EB, Neurauter A, Pedersen KW (2014)
    Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells
    Clin Ther, 36 (6), 847-862.e1
    DOI 10.1016/j.clinthera.2014.05.010, PubMed 24952935
  15. Riihijärvi S, Fiskvik I, Taskinen M, Vajavaara H, Tikkala M, Yri O, Karjalainen-Lindsberg ML, Delabie J, Smeland E, Holte H, Leppä S (2014)
    Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
    Haematologica, 100 (2), 238-45
    DOI 10.3324/haematol.2014.113472, PubMed 25381134
  16. Scott DW, Wright GW, Williams PM, Lih CJ, Walsh W, Jaffe ES, Rosenwald A, Campo E, Chan WC, Connors JM, Smeland EB, Mottok A, Braziel RM, Ott G, Delabie J, Tubbs RR, Cook JR, Weisenburger DD, Greiner TC, Glinsmann-Gibson BJ, Fu K, Staudt LM, Gascoyne RD, Rimsza LM (2014)
    Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
    Blood, 123 (8), 1214-7
    DOI 10.1182/blood-2013-11-536433, PubMed 24398326
  17. Sioud M (2014)
    Engineering better immunotherapies via RNA interference
    Hum Vaccin Immunother, 10 (11), 3165-74
    DOI 10.4161/hv.29754, PubMed 25483669
  18. Taraldsrud E, Fevang B, Aukrust P, Beiske KH, Fløisand Y, Frøland S, Rollag H, Olweus J (2014)
    Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9
    Clin Exp Immunol, 175 (3), 439-48
    DOI 10.1111/cei.12239, PubMed 24237110
  19. Yang Y, Schmitz R, Mitala J, Whiting A, Xiao W, Ceribelli M, Wright GW, Zhao H, Yang Y, Xu W, Rosenwald A, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Wiestner A et al. (2014)
    Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms
    Cancer Discov, 4 (4), 480-93
    DOI 10.1158/2159-8290.CD-13-0915, PubMed 24491438

Publications 2013

  1. Arita A, McFarland DC, Myklebust JH, Parekh S, Petersen B, Gabrilove J, Brody JD (2013)
    Signaling pathways in lymphoma: pathogenesis and therapeutic targets
    Future Oncol, 9 (10), 1549-71
    DOI 10.2217/fon.13.113, PubMed 24106904
  2. Bengnér M, Béziat V, Ernerudh J, Nilsson BO, Löfgren S, Wikby A, Malmberg KJ, Strindhall J (2013)
    Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity
    Age (Dordr), 36 (2), 571-82
    DOI 10.1007/s11357-013-9587-y, PubMed 24065293
  3. Bethge N, Honne H, Hilden V, Trøen G, Eknæs M, Liestøl K, Holte H, Delabie J, Smeland EB, Lind GE (2013)
    Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma
    PLoS One, 8 (11), e79602
    DOI 10.1371/journal.pone.0079602, PubMed 24260260
  4. Bethge N, Lothe RA, Honne H, Andresen K, Trøen G, Eknæs M, Liestøl K, Holte H, Delabie J, Smeland EB, Lind GE (2013)
    Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
    Epigenetics, 9 (3), 428-36
    DOI 10.4161/epi.27554, PubMed 24362313
  5. Béziat V, Liu LL, Malmberg JA, Ivarsson MA, Sohlberg E, Björklund AT, Retière C, Sverremark-Ekström E, Traherne J, Ljungman P, Schaffer M, Price DA, Trowsdale J, Michaëlsson J, Ljunggren HG, Malmberg KJ (2013)
    NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
    Blood, 121 (14), 2678-88
    DOI 10.1182/blood-2012-10-459545, PubMed 23325834
  6. Béziat V, Traherne JA, Liu LL, Jayaraman J, Enqvist M, Larsson S, Trowsdale J, Malmberg KJ (2013)
    Influence of KIR gene copy number on natural killer cell education
    Blood, 121 (23), 4703-7
    DOI 10.1182/blood-2012-10-461442, PubMed 23637128
  7. Brodtkorb M, Lingjærde OC, Huse K, Trøen G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie J, Holte H, Smeland EB (2013)
    Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma
    Blood, 123 (7), 1051-4
    DOI 10.1182/blood-2013-07-512392, PubMed 24357726
  8. Bödör C, Grossmann V, Popov N, Okosun J, O'Riain C, Tan K, Marzec J, Araf S, Wang J, Lee AM, Clear A, Montoto S, Matthews J, Iqbal S, Rajnai H, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Braziel RM, Staudt LM, Wright G, Lister TA et al. (2013)
    EZH2 mutations are frequent and represent an early event in follicular lymphoma
    Blood, 122 (18), 3165-8
    DOI 10.1182/blood-2013-04-496893, PubMed 24052547
  9. del Campo AB, Kyte JA, Carretero J, Zinchencko S, Méndez R, González-Aseguinolaza G, Ruiz-Cabello F, Aamdal S, Gaudernack G, Garrido F, Aptsiauri N (2013)
    Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
    Int J Cancer, 134 (1), 102-13
    DOI 10.1002/ijc.28338, PubMed 23784959
  10. Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF (2013)
    Non-allergic, mastocytosis-associated rhinitis
    Clin Exp Allergy, 43 (4), 406-12
    DOI 10.1111/cea.12053, PubMed 23517036
  11. Fedorova M, Bollineni RC, Hoffmann R (2013)
    Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies
    Mass Spectrom Rev, 33 (2), 79-97
    DOI 10.1002/mas.21381, PubMed 23832618
  12. Fiskvik I, Aamot HV, Delabie J, Smeland EB, Stokke T, Heim S, Holte H (2013)
    Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome
    Eur J Haematol, 91 (4), 332-8
    DOI 10.1111/ejh.12171, PubMed 23859481
  13. Kim YG, Lone AM, Saghatelian A (2013)
    Analysis of the proteolysis of bioactive peptides using a peptidomics approach
    Nat Protoc, 8 (9), 1730-42
    DOI 10.1038/nprot.2013.104, PubMed 23949379
  14. Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J (2013)
    Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes
    Proc Natl Acad Sci U S A, 111 (1), 403-8
    DOI 10.1073/pnas.1306549111, PubMed 24344295
  15. Kyte JA (2013)
    [The cancer riddle is outdated]
    Tidsskr Nor Laegeforen, 133 (18), 1907
    DOI 10.4045/tidsskr.13.1037, PubMed 24084948
  16. Mitchell AJ, Lone AM, Tinoco AD, Saghatelian A (2013)
    Proteolysis controls endogenous substance P levels
    PLoS One, 8 (7), e68638
    DOI 10.1371/journal.pone.0068638, PubMed 23894327
  17. Mobergslien A, Sioud M (2013)
    Exosome-derived miRNAs and cellular miRNAs activate innate immunity
    J Innate Immun, 6 (1), 105-10
    DOI 10.1159/000351460, PubMed 23774807
  18. Myklebust JH, Irish JM, Brody J, Czerwinski DK, Houot R, Kohrt HE, Timmerman J, Said J, Green MR, Delabie J, Kolstad A, Alizadeh AA, Levy R (2013)
    High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
    Blood, 121 (8), 1367-76
    DOI 10.1182/blood-2012-04-421826, PubMed 23297127
  19. Poczai P, Varga I, Laos M, Cseh A, Bell N, Valkonen JP, Hyvönen J (2013)
    Advances in plant gene-targeted and functional markers: a review
    Plant Methods, 9 (1), 6
    DOI 10.1186/1746-4811-9-6, PubMed 23406322
  20. Shahzidi S, Brech A, Sioud M, Li X, Suo Z, Nesland JM, Peng Q (2013)
    Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells
    Cancer Lett, 339 (1), 25-32
    DOI 10.1016/j.canlet.2013.07.026, PubMed 23916608
  21. Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G (2013)
    Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
    Int J Oncol, 43 (1), 280-8
    DOI 10.3892/ijo.2013.1922, PubMed 23620105
  22. Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S (2013)
    A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
    FASEB J, 27 (8), 3272-83
    DOI 10.1096/fj.12-224758, PubMed 23671272
  23. Sternberg-Simon M, Brodin P, Pickman Y, Onfelt B, Kärre K, Malmberg KJ, Höglund P, Mehr R (2013)
    Natural killer cell inhibitory receptor expression in humans and mice: a closer look
    Front Immunol, 4, 65
    DOI 10.3389/fimmu.2013.00065, PubMed 23532016
  24. Vanherberghen B, Olofsson PE, Forslund E, Sternberg-Simon M, Khorshidi MA, Pacouret S, Guldevall K, Enqvist M, Malmberg KJ, Mehr R, Önfelt B (2013)
    Classification of human natural killer cells based on migration behavior and cytotoxic response
    Blood, 121 (8), 1326-34
    DOI 10.1182/blood-2012-06-439851, PubMed 23287857
  25. Vik-Mo EO, Nyakas M, Mikkelsen BV, Moe MC, Due-Tønnesen P, Suso EM, Sæbøe-Larssen S, Sandberg C, Brinchmann JE, Helseth E, Rasmussen AM, Lote K, Aamdal S, Gaudernack G, Kvalheim G, Langmoen IA (2013)
    Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
    Cancer Immunol Immunother, 62 (9), 1499-509
    DOI 10.1007/s00262-013-1453-3, PubMed 23817721
  26. Wahlin BE, Sundström C, Sander B, Christensson B, Jeppsson-Ahlberg Å, Hjalmarsson E, Holte H, Østenstad B, Brown PD, Smeland EB, Kimby E (2013)
    Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
    Leuk Lymphoma, 55 (2), 288-95
    DOI 10.3109/10428194.2013.802778, PubMed 23662992
  27. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013)
    Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines
    PLoS One, 8 (3), e57020
    DOI 10.1371/journal.pone.0057020, PubMed 23469181
  28. Wang P, Suo Z, Wang M, Høifødt HK, Fodstad O, Gaudernack G, Kvalheim G (2013)
    In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines
    Exp Hematol Oncol, 2 (1), 16
    DOI 10.1186/2162-3619-2-16, PubMed 23738757
  29. Wälchli S, Kumari S, Fallang LE, Sand KM, Yang W, Landsverk OJ, Bakke O, Olweus J, Gregers TF (2013)
    Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation
    Eur J Immunol, 44 (3), 774-84
    DOI 10.1002/eji.201343671, PubMed 24293164
  30. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H (2013)
    Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab
    Leuk Lymphoma, 54 (10), 2205-14
    DOI 10.3109/10428194.2013.774392, PubMed 23391141
  31. Zakrzewska M, Haugsten EM, Nadratowska-Wesolowska B, Oppelt A, Hausott B, Jin Y, Otlewski J, Wesche J, Wiedlocha A (2013)
    ERK-mediated phosphorylation of fibroblast growth factor receptor 1 on Ser777 inhibits signaling
    Sci Signal, 6 (262), ra11
    DOI 10.1126/scisignal.2003087, PubMed 23405013
  32. Zins K, Thomas A, Lucas T, Sioud M, Aharinejad S, Abraham D (2013)
    Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts
    Int J Mol Sci, 14 (9), 17958-71
    DOI 10.3390/ijms140917958, PubMed 24005860

Publications 2012

  1. Anttonen T, Kirjavainen A, Belevich I, Laos M, Richardson WD, Jokitalo E, Brakebusch C, Pirvola U (2012)
    Cdc42-dependent structural development of auditory supporting cells is required for wound healing at adulthood
    Sci Rep, 2, 978
    DOI 10.1038/srep00978, PubMed 23248743
  2. Bakkebø M, Huse K, Hilden VI, Forfang L, Myklebust JH, Smeland EB, Oksvold MP (2012)
    SARA is dispensable for functional TGF-β signaling
    FEBS Lett, 586 (19), 3367-72
    DOI 10.1016/j.febslet.2012.07.027, PubMed 22819827
  3. Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
    Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
    PLoS One, 7 (9), e45422
    DOI 10.1371/journal.pone.0045422, PubMed 23028998
  4. Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ (2012)
    CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells
    Blood, 120 (17), 3455-65
    DOI 10.1182/blood-2012-03-416867, PubMed 22968455
  5. Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A (2012)
    Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
    BMC Cancer, 12, 478
    DOI 10.1186/1471-2407-12-478, PubMed 23072591
  6. Blix ES, Irish JM, Husebekk A, Delabie J, Tierens AM, Myklebust JH, Kolstad A (2012)
    Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients
    Br J Haematol, 159 (5), 604-8
    DOI 10.1111/bjh.12073, PubMed 23043253
  7. Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
    Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
    PLoS One, 7 (10), e46117
    DOI 10.1371/journal.pone.0046117, PubMed 23049692
  8. Inderberg-Suso EM, Trachsel S, Lislerud K, Rasmussen AM, Gaudernack G (2012)
    Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001
    Oncoimmunology, 1 (5), 670-686
    DOI 10.4161/onci.20426, PubMed 22934259
  9. Kim YG, Lone AM, Nolte WM, Saghatelian A (2012)
    Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides
    Proc Natl Acad Sci U S A, 109 (22), 8523-7
    DOI 10.1073/pnas.1203195109, PubMed 22586115
  10. Kumari S, Misra P, Tandon R, Samant M, Sundar S, Dube A (2012)
    Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters
    PLoS One, 7 (1), e30746
    DOI 10.1371/journal.pone.0030746, PubMed 22292030
  11. Malmberg KJ (2012)
    Toward a prime-boost regime for NK cells?
    Blood, 120 (24), 4663-4
    DOI 10.1182/blood-2012-09-457184, PubMed 23223209
  12. Malmberg KJ, Beziat V, Ljunggren HG (2012)
    Spotlight on NKG2C and the human NK-cell response to CMV infection
    Eur J Immunol, 42 (12), 3141-5
    DOI 10.1002/eji.201243050, PubMed 23255011
  13. Nilsen G, Liestøl K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, Børresen-Dale AL, Lingjaerde OC (2012)
    Copynumber: Efficient algorithms for single- and multi-track copy number segmentation
    BMC Genomics, 13, 591
    DOI 10.1186/1471-2164-13-591, PubMed 23442169
  14. Oksvold MP, Pedersen NM, Forfang L, Smeland EB (2012)
    Effect of cycloheximide on epidermal growth factor receptor trafficking and signaling
    FEBS Lett, 586 (20), 3575-81
    DOI 10.1016/j.febslet.2012.08.022, PubMed 22971756
  15. Olweus J, Kolstad A (2012)
    [Can the immune system target cancer?]
    Tidsskr Nor Laegeforen, 132 (7), 784-5
    DOI 10.4045/tidsskr.12.0156, PubMed 22511078
  16. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES et al. (2012)
    Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
    Nature, 490 (7418), 116-20
    DOI 10.1038/nature11378, PubMed 22885699
  17. Sioud M, Mobergslien A (2012)
    Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
    Biochem Pharmacol, 84 (9), 1123-32
    DOI 10.1016/j.bcp.2012.08.002, PubMed 22922046
  18. Sioud M, Mobergslien A (2012)
    Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides
    Bioconjug Chem, 23 (5), 1040-9
    DOI 10.1021/bc300050j, PubMed 22443209
  19. Yri OE, Ekstrøm PO, Hilden V, Gaudernack G, Liestøl K, Smeland EB, Holte H (2012)
    Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma
    Leuk Lymphoma, 53 (10), 1934-44
    DOI 10.3109/10428194.2012.682307, PubMed 22475179
  20. Zhen Y, Sørensen V, Skjerpen CS, Haugsten EM, Jin Y, Wälchli S, Olsnes S, Wiedlocha A (2012)
    Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1
    Traffic, 13 (5), 650-64
    DOI 10.1111/j.1600-0854.2012.01341.x, PubMed 22321063

Publications 2011

  1. Abrahamsen IW, Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J (2011)
    T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells
    Int J Cancer, 130 (8), 1821-32
    DOI 10.1002/ijc.26209, PubMed 21630262
  2. Adamczak M, Hoel HJ, Gaudernack G, Barbasz J, Szczepanowicz K, Warszyński P (2011)
    Polyelectrolyte multilayer capsules with quantum dots for biomedical applications
    Colloids Surf B Biointerfaces, 90, 211-6
    DOI 10.1016/j.colsurfb.2011.10.028, PubMed 22078925
  3. Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, Lossos IS, Levy R (2011)
    Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
    Blood, 118 (5), 1350-8
    DOI 10.1182/blood-2011-03-345272, PubMed 21670469
  4. Brunsvig PF, Kyte JA, Kersten C, Sundstrøm S, Møller M, Nyakas M, Hansen GL, Gaudernack G, Aamdal S (2011)
    Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Clin Cancer Res, 17 (21), 6847-57
    DOI 10.1158/1078-0432.CCR-11-1385, PubMed 21918169
  5. Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
    Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    BMC Res Notes, 4, 252
    DOI 10.1186/1756-0500-4-252, PubMed 21777440
  6. Corthay A, Lorvik KB, Bogen B (2011)
    Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer
    Scand J Immunol, 73 (6), 527-30
    DOI 10.1111/j.1365-3083.2011.02558.x, PubMed 21388431
  7. Eide MB, Lauritzsen GF, Kvalheim G, Kolstad A, Fagerli UM, Maisenhölder M, Østenstad B, Fluge Ø, Delabie J, Aarset H, Liestøl K, Holte H (2011)
    High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
    Br J Haematol, 152 (5), 600-10
    DOI 10.1111/j.1365-2141.2010.08519.x, PubMed 21241276
  8. Hunger RE, Kernland Lang K, Markowski CJ, Trachsel S, Møller M, Eriksen JA, Rasmussen AM, Braathen LR, Gaudernack G (2011)
    Vaccination of patients with cutaneous melanoma with telomerase-specific peptides
    Cancer Immunol Immunother, 60 (11), 1553-64
    DOI 10.1007/s00262-011-1061-z, PubMed 21681371
  9. Huse K, Bakkebø M, Oksvold MP, Forfang L, Hilden VI, Stokke T, Smeland EB, Myklebust JH (2011)
    Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7
    Eur J Immunol, 41 (11), 3135-45
    DOI 10.1002/eji.201141558, PubMed 21898381
  10. Josefsen D, Forfang L, Dyrhaug M, Blystad AK, Stokke T, Smeland EB, Kvalheim G (2011)
    Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
    Eur J Haematol, 87 (6), 494-502
    DOI 10.1111/j.1600-0609.2011.01681.x, PubMed 21752097
  11. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011)
    Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients
    Clin Cancer Res, 17 (13), 4568-80
    DOI 10.1158/1078-0432.CCR-11-0184, PubMed 21586625
  12. Malumbres R, Fresquet V, Roman-Gomez J, Bobadilla M, Robles EF, Altobelli GG, Calasanz MJ, Smeland EB, Aznar MA, Agirre X, Martin-Palanco V, Prosper F, Lossos IS, Martinez-Climent JA (2011)
    LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome
    Haematologica, 96 (7), 980-6
    DOI 10.3324/haematol.2011.040568, PubMed 21459790
  13. Mobergslien A, Sioud M (2011)
    Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
    J Leukoc Biol, 91 (3), 461-7
    DOI 10.1189/jlb.0711361, PubMed 22167721
  14. Sioud M (2011)
    New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
    Scand J Immunol, 73 (2), 79-84
    DOI 10.1111/j.1365-3083.2010.02491.x, PubMed 21198747
  15. Sioud M (2011)
    Promises and challenges in developing RNAi as a research tool and therapy
    Methods Mol Biol, 703, 173-87
    DOI 10.1007/978-1-59745-248-9_12, PubMed 21125490
  16. Sokołowska I, Wälchli S, Węgrzyn G, Sandvig K, Słomińska-Wojewódzka M (2011)
    A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation
    Biochem J, 436 (2), 371-85
    DOI 10.1042/BJ20101493, PubMed 21388347
  17. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, Gaudernack G (2011)
    hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
    Cancer Immunol Immunother, 60 (6), 809-18
    DOI 10.1007/s00262-011-0991-9, PubMed 21365467
  18. Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, Maelandsmo GM, Fodstad O (2011)
    B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
    Int J Cancer, 130 (10), 2282-90
    DOI 10.1002/ijc.26238, PubMed 21671471
  19. Tkacz-Stachowska K, Lund-Andersen C, Velissarou A, Myklebust JH, Stokke T, Syljuåsen RG (2011)
    The amount of DNA damage needed to activate the radiation-induced G2 checkpoint varies between single cells
    Radiother Oncol, 101 (1), 24-7
    DOI 10.1016/j.radonc.2011.05.060, PubMed 21722983
  20. Torfoss D, Sandstad B, Mollnes TE, Høiby EA, Holte H, Bjerner J, Bjøro T, Gaudernack G, Kvalheim G, Kvaløy S (2011)
    The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times daily
    Scand J Immunol, 74 (6), 632-9
    DOI 10.1111/j.1365-3083.2011.02618.x, PubMed 21883353
  21. Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B (2011)
    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times
    Br J Haematol, 156 (2), 225-33
    DOI 10.1111/j.1365-2141.2011.08942.x, PubMed 22126847
  22. Wälchli S, Løset GÅ, Kumari S, Johansen JN, Yang W, Sandlie I, Olweus J (2011)
    A practical approach to T-cell receptor cloning and expression
    PLoS One, 6 (11), e27930
    DOI 10.1371/journal.pone.0027930, PubMed 22132171
  23. Zakrzewska M, Sørensen V, Jin Y, Wiedlocha A, Olsnes S (2011)
    Translocation of exogenous FGF1 into cytosol and nucleus is a periodic event independent of receptor kinase activity
    Exp Cell Res, 317 (7), 1005-15
    DOI 10.1016/j.yexcr.2011.01.003, PubMed 21223966

Publications 2010

  1. Abraham D, Zins K, Sioud M, Lucas T, Schäfer R, Stanley ER, Aharinejad S (2010)
    Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
    Int J Cancer, 126 (6), 1339-52
    DOI 10.1002/ijc.24859, PubMed 19711348
  2. Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J (2010)
    Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif
    Leukemia, 24 (11), 1901-9
    DOI 10.1038/leu.2010.186, PubMed 20844564
  3. Almåsbak H, Lundby M, Rasmussen AM (2010)
    Non-MHC-dependent redirected T cells against tumor cells
    Methods Mol Biol, 629, 453-93
    DOI 10.1007/978-1-60761-657-3_28, PubMed 20387166
  4. Almåsbak H, Rian E, Hoel HJ, Pulè M, Wälchli S, Kvalheim G, Gaudernack G, Rasmussen AM (2010)
    Transiently redirected T cells for adoptive transfer
    Cytotherapy, 13 (5), 629-40
    DOI 10.3109/14653249.2010.542461, PubMed 21174490
  5. Bakkebø M, Huse K, Hilden VI, Smeland EB, Oksvold MP (2010)
    TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
    BMC Immunol, 11, 57
    DOI 10.1186/1471-2172-11-57, PubMed 21092277
  6. Ben-Mahrez K, Sioud M (2010)
    Presence of STRA-STRB linked streptomycin-resistance genes in clinical isolate of Escherichia coil 2418
    Arch Inst Pasteur Tunis, 87 (1-2), 77-81
    PubMed 21598829
  7. Bøe S, Saebøe-Larssen S, Hovig E (2010)
    Light-induced gene expression using messenger RNA molecules
    Oligonucleotides, 20 (1), 1-6
    DOI 10.1089/oli.2009.0209, PubMed 20038251
  8. Cekaite L, Clancy T, Sioud M (2010)
    Increased miR-21 expression during human monocyte differentiation into DCs
    Front Biosci (Elite Ed), 2, 818-28
    DOI 10.2741/e143, PubMed 20515755
  9. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R (2010)
    Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma
    Cell, 142 (5), 699-713
    DOI 10.1016/j.cell.2010.07.044, PubMed 20813259
  10. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E et al. (2010)
    Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
    Nature, 463 (7277), 88-92
    DOI 10.1038/nature08638, PubMed 20054396
  11. Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
    Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
    Blood, 116 (9), 1489-97
    DOI 10.1182/blood-2010-03-272278, PubMed 20505157
  12. Fløisand Y, Sioud M (2010)
    Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
    Methods Mol Biol, 629, 507-23
    DOI 10.1007/978-1-60761-657-3_30, PubMed 20387168
  13. Fredriksen L, Mathiesen G, Sioud M, Eijsink VG (2010)
    Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery
    Appl Environ Microbiol, 76 (21), 7359-62
    DOI 10.1128/AEM.01031-10, PubMed 20851975
  14. Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, Rosenstiel P, Schreiber S, Norgauer J, Platzer M (2010)
    Both copy number and sequence variations affect expression of human DEFB4
    Genes Immun, 11 (6), 458-66
    DOI 10.1038/gene.2010.19, PubMed 20445567
  15. Irish JM, Myklebust JH, Alizadeh AA, Houot R, Sharman JP, Czerwinski DK, Nolan GP, Levy R (2010)
    B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression
    Proc Natl Acad Sci U S A, 107 (29), 12747-54
    DOI 10.1073/pnas.1002057107, PubMed 20543139
  16. Iversen PO, Sørensen DR, Sioud M (2010)
    A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
    Thromb Haemost, 104 (2), 350-4
    DOI 10.1160/TH09-12-0816, PubMed 20539915
  17. Kyte JA (2010)
    [We know more than we can understand]
    Tidsskr Nor Laegeforen, 130 (22), 2217
    DOI 10.4045/tidsskr.10.1000, PubMed 21109831
  18. Kyte JA (2010)
    Third International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD 2009)
    Expert Rev Vaccines, 9 (2), 119-23
    DOI 10.1586/erv.09.157, PubMed 20109021
  19. Mobergslien A, Sioud M (2010)
    Optimized protocols for siRNA delivery into monocytes and dendritic cells
    Methods Mol Biol, 629, 71-85
    DOI 10.1007/978-1-60761-657-3_5, PubMed 20387143
  20. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, Kohlhammer H, Xu W, Yang Y, Zhao H, Shaffer AL, Romesser P, Wright G, Powell J, Rosenwald A, Muller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI et al. (2010)
    Oncogenically active MYD88 mutations in human lymphoma
    Nature, 470 (7332), 115-9
    DOI 10.1038/nature09671, PubMed 21179087
  21. Rasmussen AM, Borelli G, Hoel HJ, Lislerud K, Gaudernack G, Kvalheim G, Aarvak T (2010)
    Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy
    J Immunol Methods, 355 (1-2), 52-60
    DOI 10.1016/j.jim.2010.02.004, PubMed 20171968
  22. Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G, Wright GW, Lenz G, Ngo VN, Shaffer AL, Xu W, Zhao H, Yang Y, Lamy L, Davis RE, Xiao W, Powell J, Maloney D, Thomas CJ, Möller P, Rosenwald A, Ott G, Muller-Hermelink HK, Savage K, Connors JM et al. (2010)
    Cooperative epigenetic modulation by cancer amplicon genes
    Cancer Cell, 18 (6), 590-605
    DOI 10.1016/j.ccr.2010.11.013, PubMed 21156283
  23. Sanner H, Kirkhus E, Merckoll E, Tollisen A, Røisland M, Lie BA, Taraldsrud E, Gran JT, Flatø B (2010)
    Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study
    Arthritis Care Res (Hoboken), 62 (8), 1103-11
    DOI 10.1002/acr.20203, PubMed 20506141
  24. Sioud M (2010)
    Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
    Methods Mol Biol, 629, 33-52
    DOI 10.1007/978-1-60761-657-3_3, PubMed 20387141
  25. Sioud M (2010)
    Development of TLR7/8 small RNA antagonists
    Methods Mol Biol, 629, 387-94
    DOI 10.1007/978-1-60761-657-3_25, PubMed 20387163
  26. Sioud M (2010)
    RNA therapeutics: function, design, and delivery. Preface
    Methods Mol Biol, 629, v-vii
    DOI 10.1007/978-1-60761-657-3, PubMed 20394129
  27. Sioud M (2010)
    Recent advances in small interfering RNA sensing by the immune system
    N Biotechnol, 27 (3), 236-42
    DOI 10.1016/j.nbt.2010.02.015, PubMed 20219711
  28. Sioud M (2010)
    Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
    Methods Mol Biol, 629, 395-404
    DOI 10.1007/978-1-60761-657-3_26, PubMed 20387164
  29. Sioud M (2010)
    What are the key targeted delivery technologies of siRNA now?
    Methods Mol Biol, 629, 93-107
    DOI 10.1007/978-1-60761-657-3_7, PubMed 20387145
  30. Sioud M (2010)
    Overcoming self-tolerance to tumour cells
    Methods Mol Biol, 629, 495-505
    DOI 10.1007/978-1-60761-657-3_29, PubMed 20387167
  31. Sioud M, Cekaite L (2010)
    Profiling of miRNA expression and prediction of target genes
    Methods Mol Biol, 629, 257-71
    DOI 10.1007/978-1-60761-657-3_16, PubMed 20387154
  32. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
    Int J Oncol, 38 (2), 385-90
    DOI 10.3892/ijo.2010.869, PubMed 21165555
  33. Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
    Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
    Scand J Immunol, 71 (4), 267-74
    DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870
  34. Smeland EB, Vartdal F, Wisløff F (2010)
    [Leadership and academic competence]
    Tidsskr Nor Laegeforen, 130 (6), 591
    DOI 10.4045/tidsskr.10.0217, PubMed 20348994
  35. Smeland EB, Vartdal F, Wisløff F (2010)
    [Close cooperation, but not oversteering]
    Tidsskr Nor Laegeforen, 130 (6), 590-1
    DOI 10.4045/tidsskr.10.0153, PubMed 20348990
  36. Szczepanowicz K, Hoel HJ, Szyk-Warszynska L, Bielańska E, Bouzga AM, Gaudernack G, Simon C, Warszynski P (2010)
    Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorption
    Langmuir, 26 (15), 12592-7
    DOI 10.1021/la102061s, PubMed 20604580
  37. Sørensen DR, Sioud M (2010)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 629, 87-91
    DOI 10.1007/978-1-60761-657-3_6, PubMed 20387144
  38. Yamazaki T, Wälchli S, Fujita T, Ryser S, Hoshijima M, Schlegel W, Kuroda S, Maturana AD (2010)
    Splice variants of enigma homolog, differentially expressed during heart development, promote or prevent hypertrophy
    Cardiovasc Res, 86 (3), 374-82
    DOI 10.1093/cvr/cvq023, PubMed 20097676

Publications 2009

  1. Aharinejad S, Sioud M, Lucas T, Abraham D (2009)
    Targeting stromal-cancer cell interactions with siRNAs
    Methods Mol Biol, 487, 243-66
    DOI 10.1007/978-1-60327-547-7_12, PubMed 19301651
  2. Cekaite L, Hovig E, Sioud M (2009)
    Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
    Methods Mol Biol, 524, 273-85
    DOI 10.1007/978-1-59745-450-6_20, PubMed 19377952
  3. Copier J, Dalgleish AG, Britten CM, Finke LH, Gaudernack G, Gnjatic S, Kallen K, Kiessling R, Schuessler-Lenz M, Singh H, Talmadge J, Zwierzina H, Håkansson L (2009)
    Improving the efficacy of cancer immunotherapy
    Eur J Cancer, 45 (8), 1424-31
    DOI 10.1016/j.ejca.2008.12.017, PubMed 19167214
  4. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B (2009)
    Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells
    Cancer Res, 69 (14), 5901-7
    DOI 10.1158/0008-5472.CAN-08-4816, PubMed 19567679
  5. Flatekval GF, Sioud M (2009)
    Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
    Immunology, 128 (1 Suppl), e837-48
    DOI 10.1111/j.1365-2567.2009.03093.x, PubMed 19740345
  6. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
    Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
    Ultrastruct Pathol, 33 (4), 175-81
    DOI 10.1080/01913120903086072, PubMed 19728235
  7. Gran JT, Molberg Ø, Dobloug GC, Andersson H, Taraldsrud E, Scheie D (2009)
    [Myositis-specific autoantibodies]
    Tidsskr Nor Laegeforen, 129 (16), 1631-4
    DOI 10.4045/tidsskr.09.35501, PubMed 19721478
  8. Hauge H, Fjelland KE, Sioud M, Aasheim HC (2009)
    Evidence for the involvement of FAM110C protein in cell spreading and migration
    Cell Signal, 21 (12), 1866-73
    DOI 10.1016/j.cellsig.2009.08.001, PubMed 19698782
  9. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
    [Molecular diagnosis of malignant lymphomas]
    Tidsskr Nor Laegeforen, 129 (22), 2352-6
    DOI 10.4045/tidsskr.09.0704, PubMed 19935935
  10. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009)
    Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
    Blood, 114 (16), 3431-8
    DOI 10.1182/blood-2009-05-223958, PubMed 19641184
  11. Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
    Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
    Transl Oncol, 2 (4), 242-6
    DOI 10.1593/tlo.09154, PubMed 19956385
  12. Kyte JA (2009)
    [Nobel Prize for mitotic clock]
    Tidsskr Nor Laegeforen, 129 (23), 2470
    DOI 10.4045/tidsskr.09.1298, PubMed 19997132
  13. Kyte JA (2009)
    Cancer vaccination with telomerase peptide GV1001
    Expert Opin Investig Drugs, 18 (5), 687-94
    DOI 10.1517/13543780902897631, PubMed 19388882
  14. Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G (2009)
    Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination
    Cancer Immunol Immunother, 58 (10), 1609-26
    DOI 10.1007/s00262-009-0670-2, PubMed 19221745
  15. O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Johnson N, Gascoyne RD, Reimer S, Braziel RM, Wright GW, Staudt LM et al. (2009)
    Array-based DNA methylation profiling in follicular lymphoma
    Leukemia, 23 (10), 1858-66
    DOI 10.1038/leu.2009.114, PubMed 19587707
  16. Rölle A, Olweus J (2009)
    Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures
    APMIS, 117 (5-6), 413-26
    DOI 10.1111/j.1600-0463.2009.02449.x, PubMed 19400865
  17. Sioud M (2009)
    Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells
    Methods Mol Biol, 487, 61-82
    DOI 10.1007/978-1-60327-547-7_3, PubMed 19301642
  18. Sioud M (2009)
    Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Scand J Immunol, 70 (6), 516-25
    DOI 10.1111/j.1365-3083.2009.02326.x, PubMed 19906192
  19. Sioud M (2009)
    Deciphering the code of innate immunity recognition of siRNAs
    Methods Mol Biol, 487, 41-59
    DOI 10.1007/978-1-60327-547-7_2, PubMed 19301641
  20. Sioud M, Boudabous A, Cekaite L (2009)
    Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
    Int J Mol Med, 23 (1), 33-9
    DOI 10.3892/ijmm_00000098, PubMed 19082504
  21. Sioud M, Fløisand Y (2009)
    NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
    J Leukoc Biol, 85 (6), 939-46
    DOI 10.1189/jlb.1008650, PubMed 19244164
  22. Skånland SS, Wälchli S, Brech A, Sandvig K (2009)
    SNX4 in complex with clathrin and dynein: implications for endosome movement
    PLoS One, 4 (6), e5935
    DOI 10.1371/journal.pone.0005935, PubMed 19529763
  23. Skånland SS, Wälchli S, Sandvig K (2009)
    β-arrestins attenuate p38-mediated endosome to Golgi transport
    Cell Microbiol, 11 (5), 796-807
    DOI 10.1111/j.1462-5822.2009.01292.x, PubMed 19159388
  24. Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J (2009)
    Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells
    Scand J Immunol, 69 (4), 319-28
    DOI 10.1111/j.1365-3083.2008.02223.x, PubMed 19284496
  25. Wälchli S, Aasheim HC, Skånland SS, Spilsberg B, Torgersen ML, Rosendal KR, Sandvig K (2009)
    Characterization of clathrin and Syk interaction upon Shiga toxin binding
    Cell Signal, 21 (7), 1161-8
    DOI 10.1016/j.cellsig.2009.03.005, PubMed 19289168

Publications 2008

  1. Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
    Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
    Front Biosci, 13, 5571-9
    DOI 10.2741/3100, PubMed 18508606
  2. Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008)
    The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
    Oncogene, 27 (39), 5182-94
    DOI 10.1038/onc.2008.157, PubMed 18469852
  3. Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E (2008)
    Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape
    Int J Cancer, 123 (12), 2759-66
    DOI 10.1002/ijc.23833, PubMed 18798273
  4. Holen HL, Shadidi M, Narvhus K, Kjøsnes O, Tierens A, Aasheim HC (2008)
    Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis
    J Leukoc Biol, 84 (4), 1183-91
    DOI 10.1189/jlb.1207829, PubMed 18593733
  5. Kloster MM, Hafte TT, Moltzau LR, Naderi EH, Dahle MK, Skålhegg BS, Gaudernack G, Levy FO, Naderi S, Blomhoff HK (2008)
    EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase
    Cell Signal, 20 (6), 1169-78
    DOI 10.1016/j.cellsig.2008.02.007, PubMed 18406106
  6. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008)
    Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
    Science, 319 (5870), 1676-9
    DOI 10.1126/science.1153629, PubMed 18323416
  7. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G et al. (2008)
    Stromal gene signatures in large-B-cell lymphomas
    N Engl J Med, 359 (22), 2313-23
    DOI 10.1056/NEJMoa0802885, PubMed 19038878
  8. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008)
    Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
    Proc Natl Acad Sci U S A, 105 (36), 13520-5
    DOI 10.1073/pnas.0804295105, PubMed 18765795
  9. Maturana AD, Wälchli S, Iwata M, Ryser S, Van Lint J, Hoshijima M, Schlegel W, Ikeda Y, Tanizawa K, Kuroda S (2008)
    Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel
    Cardiovasc Res, 78 (3), 458-65
    DOI 10.1093/cvr/cvn052, PubMed 18296710
  10. Nygren MK, Døsen-Dahl G, Stubberud H, Wälchli S, Munthe E, Rian E (2008)
    beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells
    Exp Hematol, 37 (2), 225-33
    DOI 10.1016/j.exphem.2008.10.007, PubMed 19101069
  11. O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J (2008)
    The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
    Blood, 112 (8), 3126-9
    DOI 10.1182/blood-2008-05-154013, PubMed 18628487
  12. Shadidi M, Sørensen D, Dybwad A, Furset G, Sioud M (2008)
    Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
    Int J Oncol, 32 (1), 241-7
    PubMed 18097564
  13. Sioud M (2008)
    Does the understanding of immune activation by RNA predict the design of safe siRNAs?
    Front Biosci, 13, 4379-92
    DOI 10.2741/3011, PubMed 18508517
  14. Sioud M, Cekaite L (2008)
    Expression profiling of microRNAs in cancer cells: technical considerations
    Methods Mol Biol, 439, 179-90
    DOI 10.1007/978-1-59745-188-8_12, PubMed 18370103
  15. Sørensen V, Zhen Y, Zakrzewska M, Haugsten EM, Wälchli S, Nilsen T, Olsnes S, Wiedlocha A (2008)
    Phosphorylation of fibroblast growth factor (FGF) receptor 1 at Ser777 by p38 mitogen-activated protein kinase regulates translocation of exogenous FGF1 to the cytosol and nucleus
    Mol Cell Biol, 28 (12), 4129-41
    DOI 10.1128/MCB.02117-07, PubMed 18411303
  16. Walchli S, Sioud M (2008)
    Vector-based delivery of siRNAs: in vitro and in vivo challenges
    Front Biosci, 13, 3488-93
    DOI 10.2741/2943, PubMed 18508450
  17. Wester T, Jørgensen JJ, Stranden E, Sandbaek G, Tjønnfjord G, Bay D, Kollerøs D, Kroese AJ, Brinchmann JE (2008)
    Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study
    Scand J Surg, 97 (1), 56-62
    DOI 10.1177/145749690809700108, PubMed 18450207
  18. Zhang XY, Chen VL, Rosen MS, Blair ER, Lone AM, Bishop AC (2008)
    Allele-specific inhibition of divergent protein tyrosine phosphatases with a single small molecule
    Bioorg Med Chem, 16 (17), 8090-7
    DOI 10.1016/j.bmc.2008.07.053, PubMed 18678493

Publications 2007

  1. Aharinejad S, Sioud M, Lucas T, Abraham D (2007)
    Target validation using RNA interference in solid tumors
    Methods Mol Biol, 361, 227-38
    DOI 10.1385/1-59745-208-4:227, PubMed 17172715
  2. Alsøe L, Stacy JE, Fosså A, Funderud S, Brekke OH, Gaudernack G (2007)
    Identification of prostate cancer antigens by automated high-throughput filter immunoscreening
    J Immunol Methods, 330 (1-2), 12-23
    DOI 10.1016/j.jim.2007.10.011, PubMed 18045611
  3. Bishop AC, Zhang XY, Lone AM (2007)
    Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations
    Methods, 42 (3), 278-88
    DOI 10.1016/j.ymeth.2007.02.005, PubMed 17532515
  4. Borresen P, Taraldsrud E, Berentsen SA (2007)
    [A three-year-old boy with bullous skin eruptions and paresis]
    Tidsskr Nor Laegeforen, 127 (15), 1950-2
    PubMed 17708060
  5. Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N (2007)
    Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer
    Int J Cancer, 121 (7), 1433-44
    DOI 10.1002/ijc.22850, PubMed 17565747
  6. Cekaite L, Hovig E, Sioud M (2007)
    Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses
    Methods Mol Biol, 360, 335-48
    DOI 10.1385/1-59745-165-7:335, PubMed 17172738
  7. Ertesvag A, Aasheim HC, Naderi S, Blomhoff HK (2007)
    Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
    Blood, 109 (9), 3865-72
    DOI 10.1182/blood-2006-09-046748, PubMed 17209053
  8. Furset G, Fløisand Y, Sioud M (2007)
    Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
    Immunology, 123 (2), 263-71
    DOI 10.1111/j.1365-2567.2007.02695.x, PubMed 17725606
  9. Hauge H, Patzke S, Aasheim HC (2007)
    Characterization of the FAM110 gene family
    Genomics, 90 (1), 14-27
    DOI 10.1016/j.ygeno.2007.03.002, PubMed 17499476
  10. Hjorthaug HS, Aasheim HC (2007)
    Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes
    Eur J Immunol, 37 (8), 2326-36
    DOI 10.1002/eji.200737111, PubMed 17634955
  11. Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB (2007)
    Characterization of early stages of human B cell development by gene expression profiling
    J Immunol, 179 (6), 3662-71
    DOI 10.4049/jimmunol.179.6.3662, PubMed 17785802
  12. Jarnjak-Jankovic S, Hammerstad H, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines
    BMC Cancer, 7, 119
    DOI 10.1186/1471-2407-7-119, PubMed 17608923
  13. Jarnjak-Jankovic S, Saebøe-Larssen S, Kvalheim G, Gaudernack G (2007)
    mRNA transfection of DC in the immature or mature state: comparable in vitro priming of Th and cytotoxic T lymphocytes against DC electroporated with tumor cell line-derived mRNA
    Cytotherapy, 9 (6), 587-92
    DOI 10.1080/14653240701466354, PubMed 17882723
  14. Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007)
    Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
    J Exp Med, 204 (3), 633-43
    DOI 10.1084/jem.20062041, PubMed 17353367
  15. Røsok Ø, Sioud M (2007)
    Discovery of differentially expressed genes: technical considerations
    Methods Mol Biol, 360, 115-29
    DOI 10.1385/1-59745-165-7:115, PubMed 17172727
  16. Salaverria I, Zettl A, Beà S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E (2007)
    Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
    J Clin Oncol, 25 (10), 1216-22
    DOI 10.1200/JCO.2006.08.4251, PubMed 17296973
  17. Silva VS, Nunes MA, Cordeiro JM, Calejo AI, Santos S, Neves P, Sykes A, Morgado F, Dunant Y, Gonçalves PP (2007)
    Comparative effects of aluminum and ouabain on synaptosomal choline uptake, acetylcholine release and (Na+/K+)ATPase
    Toxicology, 236 (3), 158-77
    DOI 10.1016/j.tox.2007.04.017, PubMed 17560001
  18. Sioud M (2007)
    An overview of the immune system and technical advances in tumor antigen discovery and validation
    Methods Mol Biol, 360, 277-318
    DOI 10.1385/1-59745-165-7:277, PubMed 17172735
  19. Sioud M (2007)
    Main approaches to target discovery and validation
    Methods Mol Biol, 360, 1-12
    DOI 10.1385/1-59745-165-7:1, PubMed 17172722
  20. Sioud M (2007)
    RNA interference and innate immunity
    Adv Drug Deliv Rev, 59 (2-3), 153-63
    DOI 10.1016/j.addr.2007.03.006, PubMed 17459518
  21. Sioud M, Fløisand Y (2007)
    TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
    Eur J Immunol, 37 (10), 2834-46
    DOI 10.1002/eji.200737112, PubMed 17853407
  22. Sioud M, Furset G, Cekaite L (2007)
    Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
    Biochem Biophys Res Commun, 361 (1), 122-6
    DOI 10.1016/j.bbrc.2007.06.177, PubMed 17658482
  23. Sioud M, Leirdal M (2007)
    Druggable signaling proteins
    Methods Mol Biol, 361, 1-24
    DOI 10.1385/1-59745-208-4:1, PubMed 17172705
  24. Sioud M, Melien O (2007)
    Treatment options and individualized medicine
    Methods Mol Biol, 361, 327-40
    DOI 10.1385/1-59745-208-4:327, PubMed 17172721
  25. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH (2007)
    Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
    Eur J Immunol, 37 (10), 2937-48
    DOI 10.1002/eji.200636759, PubMed 17899540
  26. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI et al. (2007)
    Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
    Blood, 109 (11), 4599-606
    DOI 10.1182/blood-2006-08-039859, PubMed 17299095
  27. Zins K, Abraham D, Sioud M, Aharinejad S (2007)
    Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway
    Cancer Res, 67 (3), 1038-45
    DOI 10.1158/0008-5472.CAN-06-2295, PubMed 17283136
  28. Aamot HV, Torlakovic EE, Eide MB, Holte H, Heim S (2007)
    Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations
    J Cancer Res Clin Oncol, 133 (7), 455-70
    DOI 10.1007/s00432-006-0188-3, PubMed 17235551

Publications 2006

  1. Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006)
    Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model
    J Neurosurg, 104 (1), 109-17
    DOI 10.3171/jns.2006.104.1.109, PubMed 16509154
  2. Bernhardt SL, Gjertsen MK, Trachsel S, Møller M, Eriksen JA, Meo M, Buanes T, Gaudernack G (2006)
    Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: A dose escalating phase I/II study
    Br J Cancer, 95 (11), 1474-82
    DOI 10.1038/sj.bjc.6603437, PubMed 17060934
  3. Borowiec A, Lechward K, Tkacz-Stachowska K, Składanowski AC (2006)
    Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5'-nucleotidases
    Acta Biochim Pol, 53 (2), 269-78
    PubMed 16770441
  4. Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G (2006)
    Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
    Cancer Immunol Immunother, 55 (12), 1553-64
    DOI 10.1007/s00262-006-0145-7, PubMed 16491401
  5. Cekaite L, Furset G, Hovig E, Sioud M (2006)
    Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects
    J Mol Biol, 365 (1), 90-108
    DOI 10.1016/j.jmb.2006.09.034, PubMed 17054988
  6. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB et al. (2006)
    Molecular diagnosis of Burkitt's lymphoma
    N Engl J Med, 354 (23), 2431-42
    DOI 10.1056/NEJMoa055759, PubMed 16760443
  7. Døsen G, Tenstad E, Nygren MK, Stubberud H, Funderud S, Rian E (2006)
    Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis
    BMC Immunol, 7, 13
    DOI 10.1186/1471-2172-7-13, PubMed 16808837
  8. Ekstrøm PO, Bjørheim J (2006)
    Evaluation of sieving matrices used to separate alleles by cycling temperature capillary electrophoresis
    Electrophoresis, 27 (10), 1878-85
    DOI 10.1002/elps.200500642, PubMed 16619298
  9. Furset G, Sioud M (2006)
    Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule
    Biochem Biophys Res Commun, 352 (3), 642-9
    DOI 10.1016/j.bbrc.2006.11.059, PubMed 17150189
  10. Gaudernack G (2006)
    Prospects for vaccine therapy for pancreatic cancer
    Best Pract Res Clin Gastroenterol, 20 (2), 299-314
    DOI 10.1016/j.bpg.2006.01.003, PubMed 16549329
  11. Huynh T, Wälchli S, Sioud M (2006)
    Transcriptional targeting of small interfering RNAs into cancer cells
    Biochem Biophys Res Commun, 350 (4), 854-9
    DOI 10.1016/j.bbrc.2006.09.127, PubMed 17034763
  12. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
    Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
    Cancer Lett, 244 (2), 182-9
    DOI 10.1016/j.canlet.2005.12.010, PubMed 16427735
  13. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E (2006)
    BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
    Exp Hematol, 34 (1), 72-81
    DOI 10.1016/j.exphem.2005.09.010, PubMed 16413393
  14. Kyte JA (2006)
    [Cancer vaccines]
    Tidsskr Nor Laegeforen, 126 (22), 2969-73
    PubMed 17117197
  15. Kyte JA, Gaudernack G (2006)
    Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 55 (11), 1432-42
    DOI 10.1007/s00262-006-0161-7, PubMed 16612595
  16. Kyte JA, Kvalheim G, Lislerud K, thor Straten P, Dueland S, Aamdal S, Gaudernack G (2006)
    T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
    Cancer Immunol Immunother, 56 (5), 659-75
    DOI 10.1007/s00262-006-0222-y, PubMed 16947019
  17. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, Gullestad HP, Ryder T, Lislerud K, Hammerstad H, Gaudernack G (2006)
    Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
    Cancer Gene Ther, 13 (10), 905-18
    DOI 10.1038/sj.cgt.7700961, PubMed 16710345
  18. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K (2006)
    Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction
    N Engl J Med, 355 (12), 1199-209
    DOI 10.1056/NEJMoa055706, PubMed 16990383
  19. Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2006)
    Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines
    Br J Haematol, 136 (3), 400-13
    DOI 10.1111/j.1365-2141.2006.06442.x, PubMed 17156404
  20. Patzke S, Stokke T, Aasheim HC (2006)
    CSPP and CSPP-L associate with centrosomes and microtubules and differently affect microtubule organization
    J Cell Physiol, 209 (1), 199-210
    DOI 10.1002/jcp.20725, PubMed 16826565
  21. Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y (2006)
    DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting
    Anticancer Res, 26 (3A), 1909-16
    PubMed 16827124
  22. Saebøe-Larssen S, Fossberg E, Gaudernack G (2006)
    Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues
    BMC Mol Biol, 7, 26
    DOI 10.1186/1471-2199-7-26, PubMed 16939641
  23. Sioud M (2006)
    Ribozymes and siRnas: from structure to preclinical applications
    Handb Exp Pharmacol (173), 223-42
    DOI 10.1007/3-540-27262-3_11, PubMed 16594618
  24. Sioud M (2006)
    Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
    Eur J Immunol, 36 (5), 1222-30
    DOI 10.1002/eji.200535708, PubMed 16609928
  25. Sioud M (2006)
    RNA interference below the immune radar
    Nat Biotechnol, 24 (5), 521-2
    DOI 10.1038/nbt0506-521, PubMed 16680132
  26. Sioud M (2006)
    RNAi therapy: antibodies guide the way
    Gene Ther, 13 (3), 194-5
    DOI 10.1038/, PubMed 17243203
  27. Sioud M (2006)
    Innate sensing of self and non-self RNAs by Toll-like receptors
    Trends Mol Med, 12 (4), 167-76
    DOI 10.1016/j.molmed.2006.02.004, PubMed 16530484
  28. Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
    Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
    J Mol Biol, 364 (5), 945-54
    DOI 10.1016/j.jmb.2006.09.054, PubMed 17049554
  29. Sioud M, Furset G (2006)
    Molecular basis for the immunostimulatory potency of small interfering RNAs
    J Biomed Biotechnol, 2006 (4), 23429
    DOI 10.1155/JBB/2006/23429, PubMed 17057361
  30. Sioud M, Haoudi A (2006)
    RNA interference
    J Biomed Biotechnol, 2006 (4), 89018
    DOI 10.1155/JBB/2006/89018, PubMed 17057373
  31. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
    Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
    Leukemia, 20 (3), 539-42
    DOI 10.1038/sj.leu.2404094, PubMed 16437153
  32. Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH (2006)
    PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
    Br J Haematol, 135 (1), 117-28
    DOI 10.1111/j.1365-2141.2006.06252.x, PubMed 16965383
  33. Thomassen GO, Røsok O, Rognes T (2006)
    Computational prediction of microRNAs encoded in viral and other genomes
    J Biomed Biotechnol, 2006 (4), 95270
    DOI 10.1155/JBB/2006/95270, PubMed 17057374
  34. Winning J, Claus RA, Huse K, Bauer M (2006)
    Molecular biology on the ICU. From understanding to treating sepsis
    Minerva Anestesiol, 72 (5), 255-67
    PubMed 16675935
  35. Zheng W, Rosenstiel P, Huse K, Sina C, Valentonyte R, Mah N, Zeitlmann L, Grosse J, Ruf N, Nürnberg P, Costello CM, Onnie C, Mathew C, Platzer M, Schreiber S, Hampe J (2006)
    Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease
    Genes Immun, 7 (1), 11-8
    DOI 10.1038/sj.gene.6364263, PubMed 16222343

Publications 2005

  1. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R et al. (2005)
    Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
    Blood, 106 (9), 3183-90
    DOI 10.1182/blood-2005-04-1399, PubMed 16046532
  2. Bjørheim J, Ekstrøm PO (2005)
    Review of denaturant capillary electrophoresis in DNA variation analysis
    Electrophoresis, 26 (13), 2520-30
    DOI 10.1002/elps.200410403, PubMed 15934053
  3. Furre IE, Shahzidi S, Luksiene Z, Møller MT, Borgen E, Morgan J, Tkacz-Stachowska K, Nesland JM, Peng Q (2005)
    Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells
    Cancer Res, 65 (23), 11051-60
    DOI 10.1158/0008-5472.CAN-05-0510, PubMed 16322255
  4. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
    Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
    Leukemia, 19 (12), 2313-23
    DOI 10.1038/sj.leu.2403954, PubMed 16193090
  5. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Gaudernack G (2005)
    Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia
    BMC Cancer, 5, 20
    DOI 10.1186/1471-2407-5-20, PubMed 15720715
  6. Jarnjak-Jankovic S, Pettersen RD, Saebøe-Larssen S, Wesenberg F, Olafsen MR, Gaudernack G (2005)
    Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
    Cancer Gene Ther, 12 (8), 699-707
    DOI 10.1038/sj.cgt.7700820, PubMed 15846368
  7. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH (2005)
    BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
    BMC Immunol, 6, 9
    DOI 10.1186/1471-2172-6-9, PubMed 15877825
  8. Kyte JA, Kvalheim G, Aamdal S, Saebøe-Larssen S, Gaudernack G (2005)
    Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
    Cancer Gene Ther, 12 (6), 579-91
    DOI 10.1038/sj.cgt.7700837, PubMed 15818380
  9. Moche M, Hui DS, Huse K, Chan KS, Choy DK, Scholz GH, Gosse H, Winkler J, Schauer J, Sack U, Hoheisel G (2005)
    [Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
    Pneumologie, 59 (8), 523-8
    DOI 10.1055/s-2005-870966, PubMed 16110415
  10. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, Hammerstad H, Waehre H, Raabe N, Gaudernack G (2005)
    Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
    Br J Cancer, 93 (7), 749-56
    DOI 10.1038/sj.bjc.6602761, PubMed 16136047
  11. Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
    Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
    Oncogene, 24 (7), 1159-73
    DOI 10.1038/sj.onc.1208267, PubMed 15580290
  12. Røsok O, Sioud M (2005)
    Systematic search for natural antisense transcripts in eukaryotes (review)
    Int J Mol Med, 15 (2), 197-203
    PubMed 15647831
  13. Sioud M (2005)
    Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
    J Mol Biol, 348 (5), 1079-90
    DOI 10.1016/j.jmb.2005.03.013, PubMed 15854645
  14. Sioud M (2005)
    On the delivery of small interfering RNAs into mammalian cells
    Expert Opin Drug Deliv, 2 (4), 639-51
    DOI 10.1517/17425247.2.4.639, PubMed 16296791
  15. Sioud M (2005)
    siRNA delivery in vivo
    Methods Mol Biol, 309, 237-49
    DOI 10.1385/1-59259-935-4:237, PubMed 15990404
  16. Sioud M, Iversen PO (2005)
    Ribozymes, DNAzymes and small interfering RNAs as therapeutics
    Curr Drug Targets, 6 (6), 647-53
    DOI 10.2174/1389450054863653, PubMed 16178798
  17. Sioud M, Røsok Ø (2005)
    High-throughput analysis of microRNA gene expression using sensitive probes
    Methods Mol Biol, 309, 311-20
    DOI 10.1385/1-59259-935-4:311, PubMed 15990410
  18. Sioud M, Wälchli S (2005)
    Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
    Methods Mol Biol, 309, 83-91
    DOI 10.1385/1-59259-935-4:083, PubMed 15990399
  19. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
    PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
    J Pathol, 206 (3), 312-9
    DOI 10.1002/path.1777, PubMed 15892171
  20. Torlakovic E, Tenstad E, Funderud S, Rian E (2005)
    CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow
    J Pathol, 205 (3), 311-7
    DOI 10.1002/path.1705, PubMed 15682430
  21. Aasheim HC, Patzke S, Hjorthaug HS, Finne EF (2005)
    Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis
    Biochim Biophys Acta, 1723 (1-3), 1-7
    DOI 10.1016/j.bbagen.2005.01.011, PubMed 15777695

Publications 2004

  1. Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D (2004)
    Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
    Cancer Res, 64 (15), 5378-84
    DOI 10.1158/0008-5472.CAN-04-0961, PubMed 15289345
  2. Breivik J, Gaudernack G (2004)
    Resolving the evolutionary paradox of genetic instability: a cost-benefit analysis of DNA repair in changing environments
    FEBS Lett, 563 (1-3), 7-12
    DOI 10.1016/S0014-5793(04)00282-0, PubMed 15063714
  3. Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
    Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
    Proteomics, 4 (9), 2572-82
    DOI 10.1002/pmic.200300768, PubMed 15352232
  4. Dai KZ, Johansen FE, Kolltveit KM, Aasheim HC, Dembic Z, Vartdal F, Spurkland A (2004)
    Transcriptional activation of the SH2D2A gene is dependent on a cyclic adenosine 5'-monophosphate-responsive element in the proximal SH2D2A promoter
    J Immunol, 172 (10), 6144-51
    DOI 10.4049/jimmunol.172.10.6144, PubMed 15128801
  5. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA et al. (2004)
    Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    N Engl J Med, 351 (21), 2159-69
    DOI 10.1056/NEJMoa041869, PubMed 15548776
  6. Finne EF, Munthe E, Aasheim HC (2004)
    A new ephrin-A1 isoform (ephrin-A1b) with altered receptor binding properties abrogates the cleavage of ephrin-A1a
    Biochem J, 379 (Pt 1), 39-46
    DOI 10.1042/BJ20031619, PubMed 14692877
  7. Fosså A, Alsøe L, Crameri R, Funderud S, Gaudernack G, Smeland EB (2004)
    Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
    Cancer Immunol Immunother, 53 (5), 431-8
    DOI 10.1007/s00262-003-0458-8, PubMed 14747957
  8. Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
    NY-ESO-1 protein expression and humoral immune responses in prostate cancer
    Prostate, 59 (4), 440-7
    DOI 10.1002/pros.20025, PubMed 15065093
  9. Hauge H, Patzke S, Delabie J, Aasheim HC (2004)
    Characterization of a novel immunoglobulin-like domain containing receptor
    Biochem Biophys Res Commun, 323 (3), 970-8
    DOI 10.1016/j.bbrc.2004.08.188, PubMed 15381095
  10. Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
    Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
    P SOC PHOTO-OPT INS, 5312, 405-414
  11. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
    Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
    Clin Exp Immunol, 138 (2), 278-89
    DOI 10.1111/j.1365-2249.2004.02630.x, PubMed 15498038
  12. Iversen PO, Sioud M (2004)
    Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease
    Methods Mol Biol, 252, 451-6
    DOI 10.1385/1-59259-746-7:451, PubMed 15017070
  13. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fosså A (2004)
    Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
    Cancer Immunol Immunother, 53 (12), 1119-26
    DOI 10.1007/s00262-004-0558-0, PubMed 15185015
  14. Lazarova P, Lijun M, Hammerstad H, Nesland J, Gaudernack G, Kvalheim G (2004)
    Experimental attempt to introduce a vaccine therapy by using DC-developed from CD34+cells
    NATO SCI SER I LIFE, 361, 134
  15. Leirdal M, Shadidy M, Røsok Ø, Sioud M (2004)
    Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers
    Int J Mol Med, 14 (2), 217-22
    PubMed 15254768
  16. Leirdal M, Sioud M (2004)
    Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol
    Methods Mol Biol, 252, 493-500
    DOI 10.1385/1-59259-746-7:493, PubMed 15017074
  17. Moe JF, Sivertsen E, van Thanh D (2004)
    Adapting email functionality for mobile terminals
    LECT NOTES COMPUT SC, 3283, 199-206
  18. Mu LJ, Lazarova P, Gaudernack G, Saeboe-Larssen S, Kvalheim G (2004)
    Development of a clinical grade procedure for generation of mRNA transfected dendritic cells from purified frozen CD34(+) blood progenitor cells
    Int J Immunopathol Pharmacol, 17 (3), 255-63
    DOI 10.1177/039463200401700305, PubMed 15461859
  19. Munthe E, Finne EF, Aasheim HC (2004)
    Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells
    BMC Immunol, 5, 9
    DOI 10.1186/1471-2172-5-9, PubMed 15176971
  20. Reppe S, Olstad OK, Rian E, Gautvik VT, Gautvik KM, Jemtland R (2004)
    Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells
    Biochem Biophys Res Commun, 324 (1), 218-23
    DOI 10.1016/j.bbrc.2004.09.030, PubMed 15465005
  21. Røsok O, Sioud M (2004)
    An experimental approach for systematic identification of antisense transcripts
    Discov Med, 4 (20), 58-60
    PubMed 20705023
  22. Shadidi M, Sioud M (2004)
    Selection of peptides for specific delivery of oligonucleotides into cancer cells
    Methods Mol Biol, 252, 569-80
    DOI 10.1385/1-59259-746-7:569, PubMed 15017081
  23. Sinnreich O, Kratzsch J, Reichenbach A, Gläser C, Huse K, Birkenmeier G (2004)
    Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters
    Prostate, 61 (3), 201-8
    DOI 10.1002/pros.20062, PubMed 15368477
  24. Sioud M (2004)
    Therapeutic siRNAs
    Trends Pharmacol Sci, 25 (1), 22-8
    DOI 10.1016/, PubMed 14723975
  25. Sioud M (2004)
    Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
    Methods Mol Biol, 252, 1-8
    DOI 10.1385/1-59259-746-7:001, PubMed 15017038
  26. Sioud M (2004)
    Therapeutic potential of small interfering RNAs
    Drug Future, 29 (7), 741-750
  27. Sioud M, Leirdal M (2004)
    Potential design rules and enzymatic synthesis of siRNAs
    Methods Mol Biol, 252, 457-69
    DOI 10.1385/1-59259-746-7:457, PubMed 15017071
  28. Sioud M, Røsok O (2004)
    Profiling microRNA expression using sensitive cDNA probes and filter arrays
    Biotechniques, 37 (4), 574-6, 578-80
    DOI 10.2144/04374ST01, PubMed 15517969
  29. Sioud M, Sørensen DR (2004)
    Systemic delivery of synthetic siRNAs
    Methods Mol Biol, 252, 515-22
    DOI 10.1385/1-59259-746-7:515, PubMed 15017077
  30. Aasheim HC, Delabie J, Finne EF (2004)
    Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
    Blood, 105 (7), 2869-76
    DOI 10.1182/blood-2004-08-2981, PubMed 15585656

Publications 2003

  1. Birkenmeier G, Müller R, Huse K, Forberg J, Gläser C, Hedrich H, Nicklisch S, Reichenbach A (2003)
    Human alpha2-macroglobulin: genotype-phenotype relation
    Exp Neurol, 184 (1), 153-61
    DOI 10.1016/s0014-4886(03)00110-9, PubMed 14637088
  2. Bjorheim J, Minarik M, Gaudernack G, Ekstrom PO (2003)
    Evaluation of denaturing conditions in analysis of DNA variants applied to multi-capillary electrophoresis instruments
    J. Sep. Sci., 26 (12-13), 1163-1168
  3. Bjørheim J, Abrahamsen TW, Kristensen AT, Gaudernack G, Ekstrøm PO (2003)
    Approach to analysis of single nucleotide polymorphisms by automated constant denaturant capillary electrophoresis
    Mutat Res, 526 (1-2), 75-83
    DOI 10.1016/s0027-5107(03)00033-2, PubMed 12714185
  4. Bjørheim J, Gaudernack G, Giercksky KE, Ekstrøm PO (2003)
    Direct identification of all oncogenic mutants in KRAS exon 1 by cycling temperature capillary electrophoresis
    Electrophoresis, 24 (1-2), 63-9
    DOI 10.1002/elps.200390032, PubMed 12652573
  5. Bønsdorff T, Eggen A, Gautier M, Asheim HC, Rønningen K, Lingaas F, Olsaker I (2003)
    Identification and physical mapping of genes expressed in the corpus luteum in cattle
    Anim Genet, 34 (5), 325-33
    DOI 10.1046/j.1365-2052.2003.01023.x, PubMed 14510667
  6. Dybwad A, Lambin P, Sioud M, Zouali M (2003)
    Probing the specificity of human myeloma proteins with a random peptide phage library
    Scand J Immunol, 57 (6), 583-90
    DOI 10.1046/j.1365-3083.2003.01254.x, PubMed 12791097
  7. Kristensen AT, Bjørheim J, Wiig J, Giercksky KE, Ekstrøm PO (2003)
    DNA variants in the ATM gene are not associated with sporadic rectal cancer in a Norwegian population-based study
    Int J Colorectal Dis, 19 (1), 49-54
    DOI 10.1007/s00384-003-0519-7, PubMed 12827413
  8. Mu LJ, Gaudernack G, Saebøe-Larssen S, Hammerstad H, Tierens A, Kvalheim G (2003)
    A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines
    Scand J Immunol, 58 (5), 578-86
    DOI 10.1046/j.1365-3083.2003.01333.x, PubMed 14629630
  9. Olstad OK, Gautvik VT, Reppe S, Rian E, Jemtland R, Ohlsson C, Bruland OS, Gautvik KM (2003)
    Molecular heterogeneity in human osteosarcoma demonstrated by enriched mRNAs isolated by directional tag PCR subtraction cloning
    Anticancer Res, 23 (3B), 2201-16
    PubMed 12894494
  10. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R et al. (2003)
    Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
    J Exp Med, 198 (6), 851-62
    DOI 10.1084/jem.20031074, PubMed 12975453
  11. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC et al. (2003)
    The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
    Cancer Cell, 3 (2), 185-97
    DOI 10.1016/s1535-6108(03)00028-x, PubMed 12620412
  12. Røsok Ø, Sioud M (2003)
    Systematic identification of sense-antisense transcripts in mammalian cells
    Nat Biotechnol, 22 (1), 104-8
    DOI 10.1038/nbt925, PubMed 14704709
  13. Shadidi M, Sioud M (2003)
    Selective targeting of cancer cells using synthetic peptides
    Drug Resist Updat, 6 (6), 363-71
    DOI 10.1016/j.drup.2003.11.002, PubMed 14744500
  14. Sioud M, Sørensen D (2003)
    Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
    Eur J Immunol, 33 (1), 38-45
    DOI 10.1002/immu.200390005, PubMed 12594830
  15. Sioud M, Sørensen DR (2003)
    Cationic liposome-mediated delivery of siRNAs in adult mice
    Biochem Biophys Res Commun, 312 (4), 1220-5
    DOI 10.1016/j.bbrc.2003.11.057, PubMed 14652004
  16. Sørensen DR, Leirdal M, Sioud M (2003)
    Gene silencing by systemic delivery of synthetic siRNAs in adult mice
    J Mol Biol, 327 (4), 761-6
    DOI 10.1016/s0022-2836(03)00181-5, PubMed 12654261
  17. Wabakken T, Rian E, Kveine M, Aasheim HC (2003)
    The human solute carrier SLC41A1 belongs to a novel eukaryotic subfamily with homology to prokaryotic MgtE Mg2+ transporters
    Biochem Biophys Res Commun, 306 (3), 718-24
    DOI 10.1016/s0006-291x(03)01030-1, PubMed 12810078

Publications 2002

  1. Bjorheim J, Gaudernack G, Ekstrom PO (2002)
    Melting gel techniques in single nucleotide polymorphism and mutation detection: From theory to automation
    J. Sep. Sci., 25 (10-11), 637-647
  2. Bjørheim J, Minarik M, Gaudernack G, Ekstrøm PO (2002)
    Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries
    Anal Biochem, 304 (2), 200-5
    DOI 10.1006/abio.2002.5629, PubMed 12009696
  3. Ekstrøm PO, Bjørheim J (2002)
    Reducing the cost of consumables used for ABI 310 genetic analyzer
    Anal Biochem, 306 (1), 148-9
    DOI 10.1006/abio.2002.5656, PubMed 12069426
  4. Ekstrøm PO, Bjørheim J, Gaudernack G, Giercksky KE (2002)
    Population screening of single-nucleotide polymorphisms exemplified by analysis of 8000 alleles
    J Biomol Screen, 7 (6), 501-6
    DOI 10.1177/1087057102238623, PubMed 14599347
  5. Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
    Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
    Int J Cancer, 99 (1), 100-5
    DOI 10.1002/ijc.10286, PubMed 11948499
  6. Gjertsen MK, Saeterdal I, Saebøe-Larssen S, Gaudernack G (2002)
    HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes
    J Mol Med (Berl), 81 (1), 43-50
    DOI 10.1007/s00109-002-0390-y, PubMed 12545248
  7. Iversen PO, Emanuel PD, Sioud M (2002)
    Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
    Blood, 99 (11), 4147-53
    DOI 10.1182/blood.v99.11.4147, PubMed 12010819
  8. Kveine M, Tenstad E, Døsen G, Funderud S, Rian E (2002)
    Characterization of the novel human transmembrane protein 9 (TMEM9) that localizes to lysosomes and late endosomes
    Biochem Biophys Res Commun, 297 (4), 912-7
    DOI 10.1016/s0006-291x(02)02228-3, PubMed 12359240
  9. Leirdal M, Sioud M (2002)
    Gene silencing in mammalian cells by preformed small RNA duplexes
    Biochem Biophys Res Commun, 295 (3), 744-8
    DOI 10.1016/s0006-291x(02)00736-2, PubMed 12099702
  10. Leirdal M, Sioud M (2002)
    [Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
    Tidsskr Nor Laegeforen, 122 (2), 178-82
    PubMed 11873574
  11. Lundqvist A, Noffz G, Pavlenko M, Saebøe-Larssen S, Fong T, Maitland N, Pisa P (2002)
    Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection
    J Immunother, 25 (6), 445-54
    DOI 10.1097/00002371-200211000-00001, PubMed 12439342
  12. Machon O, van den Bout CJ, Backman M, Røsok Ø, Caubit X, Fromm SH, Geronimo B, Krauss S (2002)
    Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells
    Neuroscience, 112 (4), 951-66
    DOI 10.1016/s0306-4522(02)00053-2, PubMed 12088753
  13. Munthe E, Aasheim HC (2002)
    Characterization of the human ephrin-A4 promoter
    Biochem J, 366 (Pt 2), 447-58
    DOI 10.1042/BJ20011693, PubMed 12030849
  14. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB (2002)
    Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells
    Exp Hematol, 30 (9), 990-1000
    DOI 10.1016/s0301-472x(02)00868-8, PubMed 12225790
  15. Patzke S, Lindeskog M, Munthe E, Aasheim HC (2002)
    Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines
    Virology, 303 (1), 164-73
    DOI 10.1006/viro.2002.1615, PubMed 12482668
  16. Paulsen JE, Bjørheim J, Røe J, Eide TJ, Alexander J, Gaudernack G (2002)
    Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane
    Anticancer Res, 22 (1A), 171-5
    PubMed 12017282
  17. Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
    Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
    Anticancer Res, 22 (4), 1949-57
    PubMed 12174869
  18. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ et al. (2002)
    The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    N Engl J Med, 346 (25), 1937-47
    DOI 10.1056/NEJMoa012914, PubMed 12075054
  19. Saebøe-Larssen S, Fossberg E, Gaudernack G (2002)
    mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT)
    J Immunol Methods, 259 (1-2), 191-203
    DOI 10.1016/s0022-1759(01)00506-3, PubMed 11730854
  20. Shadidi M, Sioud M (2002)
    Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
    FASEB J, 17 (2), 256-8
    DOI 10.1096/fj.02-0280fje, PubMed 12490548
  21. Sioud M (2002)
    How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
    Mol Med, 8 (3), 115-9
    DOI 10.1007/BF03402004, PubMed 12142543
  22. Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
    Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
    Neoplasia, 4 (6), 474-9
    DOI 10.1038/sj.neo.7900271, PubMed 12407440
  23. van den Bout CJ, Machon O, Røsok Ø, Backman M, Krauss S (2002)
    The mouse enhancer element D6 directs Cre recombinase activity in the neocortex and the hippocampus
    Mech Dev, 110 (1-2), 179-82
    DOI 10.1016/s0925-4773(01)00597-4, PubMed 11744379
  24. Wabakken T, Hauge H, Finne EF, Wiedlocha A, Aasheim H (2002)
    Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase
    Scand J Immunol, 56 (2), 195-203
    DOI 10.1046/j.1365-3083.2002.01126.x, PubMed 12121439
  25. Wabakken T, Hauge H, Funderud S, Aasheim HC (2002)
    Characterization, expression and functional aspects of a novel protein tyrosine phosphatase epsilon isoform
    Scand J Immunol, 56 (3), 276-85
    DOI 10.1046/j.1365-3083.2002.01127.x, PubMed 12193229
  26. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
    Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
    BMC Bioinformatics, 3, 36
    DOI 10.1186/1471-2105-3-36, PubMed 12445336

Publications 2001

  1. Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Benamouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes HM, Zietz C, Troungos C, Valavanis C, Yuen ST, Ho JW, Croke CT et al. (2001)
    Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
    Br J Cancer, 85 (5), 692-6
    DOI 10.1054/bjoc.2001.1964, PubMed 11531254
  2. Bjørheim J, Ekstrøm PO, Fossberg E, Børresen-Dale AL, Gaudernack G (2001)
    Automated constant denaturant capillary electrophoresis applied for detection of KRAS exon 1 mutations
    Biotechniques, 30 (5), 972-5
    DOI 10.2144/01305st01, PubMed 11355359
  3. Bjørheim J, Gaudernack G, Ekstrøm PO (2001)
    Mutation analysis of TP53 exons 5-8 by automated constant denaturant capillary electrophoresis
    Tumour Biol, 22 (5), 323-7
    DOI 10.1159/000050634, PubMed 11553863
  4. Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G (2001)
    High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
    Bone Marrow Transplant, 28 (9), 849-57
    DOI 10.1038/sj.bmt.1703244, PubMed 11781645
  5. Breivik J (2001)
    Don't stop for repairs in a war zone: Darwinian evolution unites genes and environment in cancer development
    Proc Natl Acad Sci U S A, 98 (10), 5379-81
    DOI 10.1073/pnas.101137698, PubMed 11344279
  6. Gjertsen MK, Buanes T, Rosseland AR, Bakka A, Gladhaug I, Søreide O, Eriksen JA, Møller M, Baksaas I, Lothe RA, Saeterdal I, Gaudernack G (2001)
    Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma
    Int J Cancer, 92 (3), 441-50
    DOI 10.1002/ijc.1205, PubMed 11291084
  7. Hansen MH, Ostenstad B, Sioud M (2001)
    Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour
    Int J Oncol, 19 (6), 1303-9
    DOI 10.3892/ijo.19.6.1303, PubMed 11713604
  8. Hansen MH, Ostenstad B, Sioud M (2001)
    Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
    Mol Med, 7 (4), 230-9
    DOI 10.1007/BF03401842, PubMed 11471567
  9. Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J (2001)
    Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis
    Tuberculosis (Edinb), 81 (3), 203-9
    DOI 10.1054/tube.2000.0276, PubMed 11466032
  10. Hovig E, Myklebost O, Aamdal S, Smeland EB (2001)
    [Gene therapy in cancer]
    Tidsskr Nor Laegeforen, 121 (4), 482-8
    PubMed 11255868
  11. Hunger RE, Brand CU, Streit M, Eriksen JA, Gjertsen MK, Saeterdal I, Braathen LR, Gaudernack G (2001)
    Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant
    Exp Dermatol, 10 (3), 161-7
    DOI 10.1034/j.1600-0625.2001.010003161.x, PubMed 11380611
  12. Iversen PO, Nicolaysen G, Sioud M (2001)
    DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure
    Am J Physiol Heart Circ Physiol, 281 (5), H2211-7
    DOI 10.1152/ajpheart.2001.281.5.H2211, PubMed 11668085
  13. Lyngstadaas A, Smeland EB (2001)
    [Gene therapy--status and recommendations in Norwegian health care system]
    Tidsskr Nor Laegeforen, 121 (3), 343-8
    PubMed 11242880
  14. Melien O, Christoffersen T, Sioud M (2001)
    Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes
    BMC Cell Biol, 2, 13
    DOI 10.1186/1471-2121-2-13, PubMed 11495629
  15. Rian E, Wabakken T, Hauge H, Aasheim HC (2001)
    A signal sequence trap based on cell enrichment using anti-CD19 antibody coated magnetic beads
    Scand J Immunol, 54 (3), 280-4
    DOI 10.1046/j.1365-3083.2001.00925.x, PubMed 11555391
  16. Saeterdal I, Bjørheim J, Lislerud K, Gjertsen MK, Bukholm IK, Olsen OC, Nesland JM, Eriksen JA, Møller M, Lindblom A, Gaudernack G (2001)
    Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer
    Proc Natl Acad Sci U S A, 98 (23), 13255-60
    DOI 10.1073/pnas.231326898, PubMed 11687624
  17. Saeterdal I, Gjertsen MK, Straten P, Eriksen JA, Gaudernack G (2001)
    A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells
    Cancer Immunol Immunother, 50 (9), 469-76
    DOI 10.1007/s002620100222, PubMed 11761441
  18. Shadidi M, Sioud M (2001)
    An anti-leukemic single chain Fv antibody selected from a synthetic human phage antibody library
    Biochem Biophys Res Commun, 280 (2), 548-52
    DOI 10.1006/bbrc.2000.4158, PubMed 11162553
  19. Sioud M (2001)
    Nucleic acid enzymes as a novel generation of anti-gene agents
    Curr Mol Med, 1 (5), 575-88
    DOI 10.2174/1566524013363366, PubMed 11899232
  20. Sioud M, Hansen MH (2001)
    Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
    Eur J Immunol, 31 (3), 716-25
    DOI 10.1002/1521-4141(200103)31:3<716::aid-immu716>;2-9, PubMed 11241275
  21. Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H (2001)
    Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
    Br J Cancer, 85 (12), 1900-13
    DOI 10.1054/bjoc.2001.2164, PubMed 11747333

Publications 2000

  1. Ertesvåg A, Blomhoff HK, Beiske K, Naderi S (2000)
    Co-induction of Mad1 and c-Myc in activated normal B lymphocytes
    Scand J Immunol, 51 (6), 565-70
    DOI 10.1046/j.1365-3083.2000.00726.x, PubMed 10849366
  2. Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
    Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
    Br J Cancer, 83 (6), 743-9
    DOI 10.1054/bjoc.2000.1365, PubMed 10952778
  3. Hansen MH, Dybwad A, Førre O, Sioud M (2000)
    Probing antinuclear antibody specificities by peptide phage display libraries
    Clin Exp Rheumatol, 18 (4), 465-72
    PubMed 10949721
  4. Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
    Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
    Stem Cells, 18 (4), 261-72
    DOI 10.1634/stemcells.18-4-261, PubMed 10924092
  5. Leirdal M, Sioud M (2000)
    Protein kinase Calpha isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression
    Mol Cell Biol Res Commun, 4 (2), 106-10
    DOI 10.1006/mcbr.2000.0259, PubMed 11170840
  6. Munthe E, Rian E, Holien T, Rasmussen A, Levy FO, Aasheim H (2000)
    Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6
    FEBS Lett, 466 (1), 169-74
    DOI 10.1016/s0014-5793(99)01793-7, PubMed 10648835
  7. Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000)
    Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
    Blood, 95 (2), 510-8
    DOI 10.1182/blood.V95.2.510, PubMed 10627456
  8. Naderi S, Gützkow KB, Christoffersen J, Smeland EB, Blomhoff HK (2000)
    cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation
    Eur J Immunol, 30 (6), 1757-68
    DOI 10.1002/1521-4141(200006)30:6<1757::AID-IMMU1757>3.0.CO;2-N, PubMed 10898514
  9. Reppe S, Rian E, Jemtland R, Olstad OK, Gautvik VT, Gautvik KM (2000)
    Sox-4 messenger RNA is expressed in the embryonic growth plate and regulated via the parathyroid hormone/parathyroid hormone-related protein receptor in osteoblast-like cells
    J Bone Miner Res, 15 (12), 2402-12
    DOI 10.1359/jbmr.2000.15.12.2402, PubMed 11127205
  10. Røsok O, Pedeutour F, Odeberg J, Lundeberg J, Aasheim HC (2000)
    The C1orf9 gene encodes a putative transmembrane member of a novel protein family
    Biochem Biophys Res Commun, 267 (3), 855-62
    DOI 10.1006/bbrc.1999.2016, PubMed 10673381
  11. Sioud M, Hansen M, Dybwad A (2000)
    Profiling the immune responses in patient sera with peptide and cDNA display libraries
    Int J Mol Med, 6 (2), 123-8
    DOI 10.3892/ijmm.6.2.123, PubMed 10891554
  12. Sioud M, Leirdal M (2000)
    Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application
    J Mol Biol, 296 (3), 937-47
    DOI 10.1006/jmbi.2000.3491, PubMed 10677293
  13. Sioud M, Leirdal M (2000)
    Therapeutic RNA and DNA enzymes
    Biochem Pharmacol, 60 (8), 1023-6
    DOI 10.1016/s0006-2952(00)00395-6, PubMed 11007937
  14. Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale AL, DeAngelis P, Steen HB (2000)
    Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma
    Int J Cancer, 89 (4), 313-24
    DOI 10.1002/1097-0215(20000720)89:4<313::aid-ijc1>;2-d, PubMed 10956404
  15. Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T (2000)
    A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes
    Blood, 95 (1), 221-30
    DOI 10.1182/blood.V95.1.221.001k01_221_230, PubMed 10607706
Page visits: 9664